Mechanisms underlying two different FMRF amide induced ionic currents in identified neurones of 'Helix aspersa' by Falconer, Stuart W. P.
  
MECHANISMS UNDERLYING TWO DIFFERENT FMRF 
AMIDE INDUCED IONIC CURRENTS IN IDENTIFIED 
NEURONES OF 'HELIX ASPERSA' 
 
Stuart W. P. Falconer 
 
A Thesis Submitted for the Degree of PhD 
at the 
University of St Andrews 
 
 
  
1992  
Full metadata for this item is available in                                                                           
St Andrews Research Repository 
at: 
http://research-repository.st-andrews.ac.uk/ 
 
 
 
Please use this identifier to cite or link to this item: 
http://hdl.handle.net/10023/14745  
    
     
           
 
This item is protected by original copyright 
 
Mechanisms underlying two different FMRFamide induced ionic currents in identified neurones of Helix Aspersa
Stuart W.P.Falconer Department of Biology and Preclinical Medicine University of St.Andrews
A research thesis submitted for thedegree of
Doctor of Philosophy (Ph.D.)
Faculty of Science University of St.Andrews March 1992
Research Supervisor
Professor G.A.Cottrell Department of Biology and Preclinical Medicine University of St.Andrews
g
ProQ uest N u m b e r: 10170879
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10170879
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346

DECLARATIONS
I Stuart W.P. Falconer hereby clarify that this 
thesis has been composed by myself, that it is a record 
of my own work, and it has not been accepted in partial 
or complete fulfilment of any other degree or 
professional qualification.
Signed:
(Stuart W.P. Falconer)
Date: A l
I hereby clarify that the candidate has fulfilled 
the conditions of the Resolution and Regulations 
appropriate to the degree of Ph.D.
Signature of supervisor:
(Prof. G.A. Cottrell)
Date: 7 ^ -  ST-
1 1
COPYRIGHT DECLARATION
In submitting this thesis to the University of 
St. Andrews, I understand that I am giving permission 
for it to be made available for use in accordance with 
the regulations of the University library for the time 
being in force, subject to any copyright vested in the 
work not being affected hereby. I also understand that 
the title and abstract will be published, and that a 
copy of the work may be made and supplied to any bona 
fide library or research worker.
1
1 1 1
ACKNOWLEDGEMENTS
I wish to thank my supervisor Professor Glen 
Cottrell for his help and guidance throughout this 
research project. In addition I would like to thank 
Dr. Steve Logan, University of Birmingham (External 
examiner) and Dr. Robert M.Pitman, University of 
St.Andrews (Internal examiner), for their assessment of 
this research thesis. I am grateful to Mr. Brian Powell 
for his technical assistance and for the friendship 
afforded to me by my colleagues in the laboratory. I also 
wish to thank Dr. Simon Robinson for his friendship, help 
and suggestions in compiling this thesis. I acknowledge 
the support of the SERC for the funding of this three 
year postgraduate research project.
IV
DEDICATION
I respectfully dedicate this research thesis to my 
wife Jacqueline and my family for their continued love 
and support during this project.
Abstract
VApplication of the molluscan neuropeptide 
FMRFamide to two identified neurones in the cerebral 
ganglia of Helix aspersa induces quite different 
effects. In the Cl neurone, FMRFamide produces a slow 
hyperpolarizing current carried by K"** while with the C2 
neurone it causes a fast depolarizing current carried 
by Na^. Possible mechanisms underlying the slow 
response were examined and the fast response was 
characterized using voltage clamp techniques. Some 
patch clamp experiments were also used for the slow K**" 
response.
The slow K"^  response was shown to depend on a G 
protein, which was sensitive to inhibition by pertussis 
toxin, indicating that it was mediated by a or G q  
protein. Second messengers such as cyclic AMP, cyclic 
GMP, IP3 , arachidonic acid and Ca^^ along with the 
activation of protein kinase C were all found not to be 
directly involved in producing the FMRFamide response. 
These negative results with the second messengers gave 
rise to the view that the FMRFamide receptors and 
ion channels may be linked directly through the 
activation of G proteins.
5-HT, probably acting through raised cyclic AMP 
levels, reduced the amplitude of the FMRFamide response 
which suggests that the channel opened by FMRFamide may 
be an "S" K"'* type channel. Activation of protein kinase 
C by phorbol ester also reduced the FMRFamide response. 
A role for protein phosphorylation was indicated by the 
use of okadaic acid which inhibits protein phosphatases 
1 and 2A. Its application reduced the amplitude of the
VI
FMRFamide response which suggested that increased 
protein phosphorylation levels lead to smaller 
responses. Thus, it seemed possible that protein 
phosphorylation levels controlled by cyclic AMP, 
protein kinase C activation and protein phosphatases 1 
and 2A might modulate the activity of the receptor/ G 
protein/ ion channel complex. Alternatively, FMRFamide 
may operate through the activation of protein 
phosphatase(s) which reduce protein phosphorylation 
levels.
Patch clamp studies in cell attached mode on the 
Cl neurone failed to reveal any channel openings 
induced by FMRFamide. This result also tends to rule 
out the direct involvement of a second messenger.
The fast depolarizing FMRFamide response of the 02 
neurone, which is due to the opening of a ligand gated 
channel, was found to be carried by Na"^  and not Ca^^. 
Amiloride produced a reversible block of the current. 
Tetrodotoxin and lignocaine had no effect on the 
FMRFamide response while raised cyclic AMP levels 
potentiated the response. In the presence of okadaic 
acid and increased levels of cyclic AMP, the FMRFamide 
response is potentiated. This potentiation was not 
maintained in the presence of okadaic acid alone. The 
raised protein phosphorylation levels therefore did not 
cause potentiation, which suggested that cyclic AMP may 
have a direct effect on the receptor/channel complex.
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Chapter 1 
Introduction
1.1 INTERNEURONAL COMMUNICATION
To perform its task of controlling and integrating 
the function of multicellular organisms, the nervous 
system must have rapid communication between its 
individual neurones. Interneuronal communication occurs 
at sites known as synapses.
Synapses are separated into two categories, 
electrical and chemical. Electrical synapses are those 
where currents produced by an impulse in the 
presynaptic nerve terminal pass directly to the 
postsynaptic neurone through a low resistance pathway. 
These electrical communication sites appear in electron 
micrographs as gap junctions. There is no measurable 
delay with this type of transmission. Chemical synapses 
operate through a mechanism whereby a chemical 
substance (neurotransmitter) is released from the 
presynaptic terminal and diffuses across the synaptic 
gap to the postsynaptic neurone. The neurotransmitter 
then binds to receptors on the postsynaptic neurone and 
alters the membrane conductance to specific ions. 
Transmission across chemical synaptic junctions 
involves time delays of fractions of milliseconds.
1.2 NEUROTRANSMITTERS
Neurotransmitters may be grouped into two broad 
categories. There are the low molecular weight 
compounds, examples of which are acetylcholine (ACh), 
noradrenaline (NA), dopamine, 5-hydroxytryptamine (5- 
HT), *-aminobutyric acid (GABA), glutamate and glycine.
pNeurones possess the necessary biochemical machinery to 
synthesize these compounds at the terminal release 
sites. Also, enzymes are present which allow the 
compounds to be quickly degraded and/or re-uptaken into 
the terminals following their release. Rapid turnover 
of these compounds is a great advantage since supplies 
of neurotransmitter can be rapidly replenished 
following vigorous or lengthy stimulation.
Peptides fall into the second category of 
neurotransmitter substances. For many years peptides 
have been established as chemical messengers in the 
endocrine systems of multicellular animals. They are 
released into the bloodstream or haemolymph and 
transported often considerable distances to their 
target sites (chemically addressed), where they can 
have long lasting actions. However, it is now generally 
accepted that following the isolation and 
identification of a great number of peptides from 
nervous tissue throughout the animal kingdom and 
examining their wide ranging actions, that they also 
fulfill the role of the neurotransmitter. They are 
commonly known as neuropeptides and will be referred to 
as such throughout this thesis.
Neuropeptides, unlike the low molecular weight 
neurotransmitters can not be synthesized at the 
presynaptic nerve terminals. Instead they are produced 
from larger precursors which are synthesized on 
ribosomes within the cell body. This means that the 
neuropeptides must be transported over a long distance 
down the axon to release sites at the synaptic
-  ■ ■ ■ ■ - ,  . . . . . .  .  ^ %
terminals. The amount of neuropeptide which can be 
transported is small compared with the amount of low ^
molecular weight transmitter that can be synthesized or %
taken up at the terminal. Thus, if the available supply :
of neuropeptide at the terminals is not to be 
exhausted, only a small amount of neuropeptide can be 
released at any one time. It seems feasible that some 
of the roles of neuropeptides may have been superseded 
by low molecular weight transmitters where a rapid 
turnover of neurotransmitter is required.
1.3 NEUROMODULATORS
The terminology regarding the actions of 
neuropeptides is controversial. Due to the facts that 
these actions are often slow in timecourse, that the 
sites of action may be fairly widespread rather than 
localized and that coexistance with low molecular 
weight neurotransmitters is common, they are often 
referred to as neuromodulators rather than 
neurotransmitters. Since the term "neuromodulatory" has 
been used in numerous ways it is important to define 
what it means in the context of this thesis. A 
neuromodulator will refer to a neuropeptide which only 
influences the actions of other synaptic connections.
The site of modulation may be postsynaptic where the 
neuropeptide can change the repense of a cell to other 
neurotransmitters. Alternatively, it can be presynaptic 
where the neuropeptide alters the release of other 4
¥
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neurotransmitters from the terminals. Examples of 
neuromodulatory actions will be described later.
1.4 LOCALIZATION AND CHARACTERIZATION OF NEUROPEPTIDES
The localization and characterization of 
neuropeptides in nervous systems can be problematic, 
mainly because of the small amounts present in a given 
tissue. Nevertheless there are now numerous examples of 
neuropeptides present in nervous tissue.
One method frequently used to detect neuropeptides 
is that of immunohistochemistry. Although this approach 
is both useful and powerful, the results should be 
considered with caution because it is common for 
antisera to cross react with structurally related 
immunogens. Much of the early neuropeptide 
identifications were carried out using 
immunohistochemistry. However, with the development of 
highly sensitive radioimmunoassay (RIA) and high 
performance liquid chromatography (HPLC) techniques, it 
is now possible to purify and chemically identify 
neuropeptides from small numbers of neurones.
1.5 NEUROPEPTIDES OF VERTEBRATE NERVOUS SYSTEMS
A substantial amount of the present knowledge 
regarding the localization, characterization, 
distribution, release, receptors for, actions of, and 
roles for neuropeptides has been obtained from work
performed on vertebrate nervous systems. Therefore some 
of this information will be considered first of all.
1.5.1 LOCALIZATION. CHARACTERIZATION AND DISTRIBUTION
Since it is now known that there is a large number 
of neuropeptides present in vertebrate nervous systems, 
only a few examples are considered here.
In 1971 the chemical structure of substance P, a 
member of the tachykinin neuropeptide family was first 
determined (Chang et a l . 1971). Fairly soon after this, 
Otsuka et al (1972) isolated a peptide from the dorsal 
root of bovine spinal cord. This was identified as 
substance P. Considerable amounts of substance P have 
been identified using immunohistochemical techniques in 
a certain population of primary sensory neurones of the 
cat, namely the C group which are thin nerve fibres. 
These nerve fibres are associated with pain 
transmission, which points to at least one 
physiological function of substance P (Hokfelt et al. 
1975). Ten years after the discovery of substance P, it 
was still the only tachykinin isolated from mammalian 
sources. In 1983, two novel tachykinin peptides, 
neurokinin A and neurokinin B were discovered (Kimura 
et alf 1983).
Since this discovery of neurokinin A and 
neurokinin B in the rat, studies of the regional 
distribution of these neuropeptides have been carried 
out and compared with substance P (Kanazawa et al,
1984; Aral and Emson, 1986). Substantial amounts have
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been found in the substantia nigra, striatum, spinal 
cord, cerebral cortex and cerebellum. Although the 
amount of neurokinin A present in the tissues was 
relatively small compared to substance P, both 
neuropeptides exhibited nearly the same distribution 
pattern. Neurokinin B was found in considerably higher 
amounts than the other neuropeptides in the cerebral 
cortex.
Another neuropeptide found at its highest level in 
the cerebral cortex of the rat was cholecystokinin 
(CCK). In the regional distribution study performed by 
Beinfeld et al (1981), intermediate levels were also 
found in the striatum, thalamus and hypothalamus. Most 
of the work performed on CCK has concentrated on the 
octapeptide known as CCK-8S, although other forms do 
exist. CCK-8S appears to be the most abundant form 
found in brain extracts (Larsson and Rehfeld, 1979).
CCK is present in the nervous system at concentrations 
that exceed the other neuropeptides (Iversen, 1983).
A few years after the discovery of substance P, 
endogenous opiate neuropeptides known as Met-enkephalin 
and Leu-enkephalin were also isolated from mammalian 
brain (Hughes et al. 1975).
When considering the localization, 
characterization and distribution of neuropeptides an 
important point to emphasize is that in most 
circumstances, they are co-localized with lower 
molecular weight neurotransmitters. A good example of 
co-localization is provided in the bullfrog sympathetic 
ganglion. Neurones in some ganglia of the lumbar chain
,3
1contain ACh and a luteinizing hormone releasing hormone 
(LHRH)-like peptide (Branton et al, 1986). The 
significance of this co-localization will be described ^
in a later section of this chapter.
1.5.2 NEUROPEPTIDE RELEASE
It is important to know if neuropeptides are 
released from presynaptic terminals in a Ca^^ dependent 
manner following depolarization, as is the case with 
low molecular weight neurotransmitters. Evidence has 
shown that this is indeed what happens with several 
neuropeptides.
Henderson et al (1978) examined the release of 
Met- and Leu- enkephalin from synaptosomes produced 
from the corpus striatum. They found using the mouse 
vas deferens as a bioassay system that the basal 
release of enkephalin was greatly increased during 
depolarizations induced by high K"^  concentrations, or 
vertridine. When the Ca^ '*“ concentration was reduced 
then the amount of enkephalin released was much 
smaller.
In perfused preparations of rat frontal lobe and 
striatum, neurokinin A and neurokinin B were shown to 
be released under high K"*" concentrations in the 
presence of Ca2+, as was substance P (Linderfors et al,
1985). CCK was released in a Ca^^ dependent manner from 
rat synaptosomes and brain slices in the presence of 
high K"*" concentrations (Dodd et al. 1980).
1.5.3 NEUROPEPTIDE RECEPTORS
The existance of multiple receptors for the 
binding of released neuropeptides in the nervous system 
are now well documented, two examples of which are 
given below.
Receptors for the three mammalian tachykinins have 
now been divided into three types, namely NK-1 
(substance P-suceptive), NK-2 (neurokinin A-suceptive) 
and NK-3 (neurokinin B-suceptive). These receptors have 
been located in the areas close to where the endogenous 
tachykinins are distributed in the nervous system.
Interestingly, Masu et al (1987) have been able to 
express the gene encoding the receptor of neurokinin A 
in Xenopus oocytes and to deduce the amino acid 
sequence of the receptor protein using the combination 
of electrophysiological and cloning techniques. The 
protein structure anticipated from the primary 
structure is a seven-transmembrane segment feature and 
belongs to the superfamily of the GTP-binding protein 
group (G protein). Also Segawa and Nakata (1991) have 
shown that substance P receptors may couple with 
pertussis toxin sensitive G proteins. This implies that 
these neuropeptides operate through one, or more, of 
the well characterized signal transduction mechanisms.
Multiple receptors have also been identified for 
the endogenous opioid neuropeptides. These are known as 
/i, S and k (Martin et al. 1976; Lord et al. 1977). It 
was shown by Snyder (1980) that binding sites for 
opioid neuropeptides are close to neuronal terminals i
I
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which are immunoreactive for enkephalin and to involve 
areas of the central nervous system which have been 
linked with opioid actions. Association of fi and k 
receptor types with signal transducing G proteins has 
been shown (Ueda et al. 1991). As with substance P, 
this suggests that the opioid neuropeptides may operate 
through one or more of the well known signal 
transduction mechanisms. The situation with the S 
opioid receptor is different in that it does not pass 
on a signal to the G proteins, despite some interaction 
between them. Therefore, this is not a functional 
association between G protein and receptor as regards 
signal transduction.
1.5.4 EFFECTS OF NEUROPEPTIDES ON VERTEBRATE NEURONES
Many studies have been performed to determine how 
neuropeptides influence vertebrate neuronal activity as 
neurotransmitters and to elucidate when possible, the 
intracellular mechanisms underlying these effects. With 
the availablity of intracellular recording and patch 
clamp techniques, substantial quantities of endogenous 
neuropeptides, selective receptor agonists and 
antagonists and various powerful intracellular 
biochemical probes, a vast amount of important data has 
now been published. A selection of these data will be 
considered in this section.
A proposed physiological role for substance P is 
that of a pain transmitter (Hokfelt et al, 1975). This 
neuropeptide has also been established as an excitatory
1 0
transmitter. When spinal cord preparations of new-born 
rats were subjected to substance P application, a 
depolarizing effect was observed (Konishi and Otsuka, 
1974). With bullfrog lumbar sympathetic neurones under 
current clamp conditions, substance P produced a 
depolarization which was associated with an increase in 
membrane input resistance. When these neurones were 
voltage clamped the neuropeptide induced an inward 
current which was due to the inhibition of a voltage- 
dependent current, otherwise known as the M-current 
(Adams et al. 1983). The excitatory action of substance 
P observed on cultured magnocellular cholinergic 
neurones from newborn rat brains was found to be due to 
the reduction of an inwardly rectifying K"^  conductance 
(Stanfield et al. 1985). The steps between the binding 
of substance P to its receptor and the closure of the 
channels were not investigated, although it was 
suggested that an intracellular second messenger system 
is probably involved. Very little is known about the 
intracellular events which underlie the effects of the 
tachykinin neuropeptides on neurones. However, there is 
evidence which indicates that these neuropeptides 
stimulate the inositol phospholipid system in rat 
salivary glands (Hanley et al , 1980).
Neurokinin A and neurokinin B, similar to 
substance P, have been shown to have depolarizing 
effects on isolated spinal cord neurones of the new 
born rat (Matsuto et a l , 1984).
When the endogenous opioid neuropeptides Met- 
enkephalin and B-endorphin were applied to neurones of
1 1
the rat locus coeruleus and the guinea pig ileum 
submucous plexus, they induced a concentration 
dependent hyperpolarization. This registered as an 
outward current when the neurones were voltage clamped 
close to their resting potential (North et al , 1987).
It was due to the increased conductance of an inwardly 
rectifying current. Specific agonists of p; and 6 
receptors were used on neurones of both tissues and the 
conclusion reached was that the rat locus coeruleus 
neurones express only p receptors and that the guinea 
pig submucous neurones express only 8 receptors. It was 
shown with the non-hydrolysable analogue of GTP, GTPfS, 
that a G protein was involved in the coupling between 
both opioid receptors and the channel. There was no 
evidence to suggest that activation of cyclic AMP 
dependent protein kinase, or protein kinase C, were 
involved in the increase in K"^  conductance. The 
involvement of other second messenger systems was not 
tested.
Since then, the p-opioid receptor has been shown 
to activate inwardly rectifying conductances through 
a pertussis toxin sensitive G protein in rat locus 
coeruleus neurones (Williams et al. 1988). Of the two 
types of G protein which are sensitive to pertussis 
toxin, namely G^ and Go, was negatively coupled to 
the adenylate cyclase enzyme. The p-opioid receptor has 
also been shown to inhibit adenylate cyclase in human 
neuroblastoma SH-SY5Y cells (Kazmi and Mishra, 1987). 
Activation of p-opioid receptors in SH-SY5Y cells 
inhibited an N-type Ca^^ channel (Seward et al, 1991).
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This group found that although coupling between the p- 
receptor and Ca^+ channel involved a pertussis toxin 
sensitive G protein, inhibition of adenylate cyclase 
did not occur.
The action of a LHRH-like neuropeptide on bullfrog 
sympathetic neurones has provided an interesting 
insight into the concept of co-localization of 
neuropeptides and low molecular weight 
neurotransmitters. It is known that neurones in some 
lumbar chain ganglia contain the LHRH-like neuropeptide 
along with ACh and it appears that preganglionic C- 
fibres release both substances (Branton et al, 1986). 
However, while ACh acts only on the C-cells which are 
synaptically connected to preganglionic C-fibres which 
release ACh, the LHRH-like neuropeptide acts not only 
on some C-cells but also B-cells which are not in 
synaptic contact with the C-fibres. The 
electrophysiology has shown that ACh causes fast 
excitatory postsynaptic potentials (epsps) and the 
LHRH-like neuropeptide induces non cholinergic, late 
slow epsps. Therefore, although both ACh and the LHRH- 
like neuropeptide are released from the same neurones, 
they can operate on different target cells and cause 
different electrophysiological effects on these 
neurones. The individual effects of these 
neurotransmitters are clearly dependent upon the 
differential distribution of receptors on target cells 
and the ability of the LHRH-like neuropeptide to 
survive substantial diffusional distances (up to lOjum 
when operating on B-cells).
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Somatostatin is another neuropeptide which has 
effects on neuronal M currents. However, whereas 
substance P inhibited the M current in bullfrog 
sympathetic neurones, somatostatin augmented the M 
current in rat hippocampal neurones (Schweitzer et al,
1990). This group showed that the second messenger 
pathway involving arachidonic acid underlies the 
effects of somatostatin in these neurones. In this 
pathway, arachidonic acid is produced by the action of 
phospholipase À 2 on esterified stores of membrane 
phospholipids. Arachidonic acid may then be further 
metabolized to leukotrienes by lipoxygenase enzymes.
Oxidized arachidonic acid metabolites such as the 
leukotrienes are known as eicosanoids. It was shown 
that arachidonic acid and leukotriene C 4 mimicked the 
effects of somatostatin. Also, inhibitors of 
phospholipase À 2 abolished the effects of somatostatin.
This was thought to be the first electrophysiological 
evidence for eicosanoid mediation of a neurotransmitter 
effect in a vertebrate central neurone. |
The effect of CCK-8 S on a subtype of neurone |
located in the ventromedial nucleus of the hypothalamus |
was investigated by Boden and Hill (1988). This brain |
■lregion was examined since binding sites for CCK-8 S are I
known to be present (Day et al, 1986) and CCK is |
believed to play a role in appetite regulation in this 
instance (Baile et a l , 1986). CCK-8 S induced excitation 
of these neurones which were already spontaneously 
active through the activation of CCK receptors. When 
the neurones were voltage clamped, it was shown that
14
this excitation is due in part to the reduction of an M 
current via a pertussus toxin insensitive G protein.
A good example where the intracellular mechanism 
underlying the excitatory effect of a neuropeptide on 
vertebrate neurones has been examined, is that of 
bradykinin on cultured rat dorsal root ganglion (DRG) 
neurones (Burgess et al, 1989), Bradykinin is a pain 
producing peptide formed at the site of injury and 
stimulates peripheral terminals of sensory afferent 
fibres. When it was applied to the DRG neurones, there 
was a depolarizing inward current with an increase in 
membrane conductance and it was thought that this was 
probably due to the opening of Na"^  channels. An 
additional effect of bradykinin was the uptake of 
45c&2+ into the neurones through Ca^^ channels. When 
protein kinase C was activated by phorbol esters, there 
was a mimic of both the depolarization and 
uptake of the neurones. When protein kinase C was 
either blocked with staurosporine or down regulated 
with prolonged exposure to phorbol esters, the effects 
of bradykinin were no longer seen. In addition, 
bradykinin also activated phospholipase C in DRG 
neurones which elevated inositol 1 ,4,5-trisphosphate 
(IP3 ) and diacylglycerol (DAG) levels. The latter 
compound is an endogenous activator of protein kinase 
C, thus it is thought that protein kinase C activation 
may underlie some effects of bradykinin in sensory 
neurones.
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1.5.5 MODULATORY ROLES OF NEUROPEPTIDES ON VERTEBRATE i
NEURONES
Neuropeptide Y has been shown to have important 
modulatory effects as regards the release of 
neurotransmitter and alteration of 0 3 ?+ currents in 
different neurones. Using cultured DRG neurones Walker 
et al, (1988) found that neuropeptide Y potently 
inhibited Ca^+ currents (transient and sustained) under 
voltage clamp conditions. Pre-treatment of the neurones 
with pertussis toxin blocked the effects of 
neuropeptide Y hence implicating the involvement of a G 
protein (Gj^  or Gq). When Ca^+ influx was determined 
using microspectrofluorimetry it was found that 
depolarization induced influxes were partially 
inhibited by neuropeptide Y. Consistent with the 
results on Ca^+ currents, neuropeptide Y also inhibited 
the depolarization induced release of substance P from 
DRG neurones. It was suggested that this neuropeptide 
may be an important regulator of sensory function in 
vitro.
Members of the same group (Ewald et al. 1988) 
investigated the intracellular events which might 
underlie Ca^+ current inhibition in these neurones by 
neuropeptide Y. They found that protein kinase C was 
important, although the exact role of this enzyme may 
depend on the type of Ca^+ channel involved.
The actions of neuropeptide Y have also been 
examined in dissociated cultured vagal sensory (nodose) 
neurones (Wiley et a l , 1990). These neurones have three
'T,
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C&2+ current components; a transient low threshold (T) 
current, a slowly inactivating high threshold (L) 
current and a transient high threshold (N) current. 
Neuropeptide Y reduced the N current component and 
inhibited K+ evoked release of ACh. When the cultured 
neurones were pre-treated with pertussis toxin, these 
effects of neuropeptide Y were blocked. The results 
indicated that the entry of Ca^+ through N-type 
channels into these neurones may be coupled selectively 
to the release of ACh, and that neuropeptide Y can 
inhibit the release by acting through a pertussis toxin 
sensitive G protein.
Selective agonists for opioid receptors (fi, S o r  
k) modulate the electrically stimulated release of Met- 
enkephalin from guinea pig myenteric plexus. Low doses 
of opioids enhance release whereas higher 
concentrations inhibit release. The mechanism of action 
of this modulation has been investigated by Gintzler 
and Xu, (1991). Whilst pre-treatment of the preparation 
with pertussis toxin reduced the potency of /x, <S, or k 
receptors to selective agonists to inhibit the release 
of enkephalin, it did not effect the enhancement of 
release. In contrast, when the preparation was 
pretreated with cholera toxin, inhibition of release 
was unaffected but enhancement of release was 
abolished. These results showed that a pertussis toxin 
sensitive G protein (Gq or Gj^ ) mediates the inhibition 
of release by opioids, and a cholera toxin sensitive G 
protein (Gg) mediates enhancement of release.
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Somatostatin is a neuropeptide which has been 
shown to have a modulatory action on neurones of the 
rat hippocampus and parietal cortex that can respond to 
ACh (Mancillas et al, 1986). Both of these brain 
regions contain areas where somatostatin and 
cholinergic nerve terminals overlap. It was discovered 
that somatostatin application alone inhibited 
spontaneous firing of nearly all neurones tested 
whereas, ACh alone enhanced their firing. When both 
substances were applied simultaneously, the ACh 
excitations were enhanced by 78%. The ability of 
somatostatin to produce this effect was dose-dependent 
and also seemed to be specific for ACh, since it did 
not enhance the responsiveness to pulses of the 
excitatory amino acid glutamate. The site of 
modulation, whether pre- or postsynaptic, was not 
determined.
The action of neurotensin on autoreceptor-mediated 
dopamine effects on rat midbrain dopamine cell activity 
(Shi and Bunney, 1991) is another interesting example 
of a neuropeptide modulatory action. In this case, the 
concept of autoreceptors is used which means a neurone 
having receptors for, and its activity being regulated 
by a transmitter substance released by itself. 
Neurotensin produced a marked attenuation of the 
inhibitory effect of either dopamine or the specific D 2  
agonist quinpirole. The intracellular events underlying 
this modulatory effect remain to be elucidated.
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1.6 NEUROPEPTIDES OF INVERTEBRATE NERVOUS SYSTEMS
1.6.1 ISOLATION AND CHARACTERIZATION
The major problem facing investigators interested i
in isolating and characterizing neuropeptides from 
invertebrate animals has been the small quantities 
present in their nervous systems. In early studies it 
was a regular occurrence to use hundreds of animals to 
purify tiny amounts of neuropeptide. Given these 
difficulties it was surprising to find that one of the 
first peptides sequenced was eledoisin which originated 
from salivary glands of the octapod Eledone (Erspamer 
and Anastasi, 1962). However, it should be noted that 
salivary glands provided a larger bulk of tissue 
compared to neuronal tissue. Eledoisin was the first 
member of the tachykinin family to be isolated. The 
tachykinin family of neuropeptides also include 
substance P, neurokinin A and neurokinin B.
A number of endogenous invertebrate neuropeptides 
have now been isolated and characterized. Many of them 
originate from arthropod and molluscan species.
Proctolin and the Phe-Met-Arg-Phe-NH2 (FMRFamide) 
related peptides have probably been studied in the most 
detail. A great deal of information has been presented, 
not only regarding their localization and 
characterization, but also their physiological effects 
on nerve and muscle tissue. Since the experiments 
decribed in this thesis are concerned with the actions
0
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of FMRFamide on identified neurones, attention will now 
be focussed on the FMRFamide-related peptides,
1.6.2 DISCOVERY OF FMRFamide
When extracts of molluscan ganglia were studied by 
Frontali, Williams and Welsh (1967), most of the 
cardioactive material was found in the chromatographic 
fraction which was designated as "peak c". They also 
discovered that these partially purified substances 
were susceptible to proteolytic enzyme breakdown, hence 
indicating their pepdidergic nature. Price and 
Greenberg, (1977) isolated peak c from ganglia extracts 
of the sunray clam Macrocallista nimbosa. This was 
achieved using the the heart of the clam Mercenaria 
mercenaria and the radula protractor muscle of Busycon 
as bioassays. Analysis of peak c material was carried 
out using solvent extractions, gel filtration and ion 
exchange chromatography. It was found to consist of the 
amidated tetrapeptide Phe-Met-Arg-Phe-NH2 following 
amino acid analysis. This neuropeptide is referred to 
as "FMRFamide" using the single letter abbreviation 
system for the amino acids comprising its structure.
As people became more interested in FMRFamide, it 
became clear that it was only one member of an 
expanding family of related neuropeptides. Most of the 
FMRFamide-related peptides are extended at the N- 
terminus and have a leucine (Leu, L) substitution for 
methionine (Met, M) at postion 2 of the FMRFamide
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molecule. The tetrapeptide FLRFamide is also a member 
of this family.
1.6.3 LOCALIZATION. ISOLATION AND CHARACTERIZATION 
OF THE FMRFamide RELATED PEPTIDES
Evidence has shown that the FMRFamide related 
peptides are present in many different species.
Antibodies raised against the C-terminus of the 
FMRFamide molecule for histochemical studies have 
revealed immunoreactive material in nerve and muscle 
tissue of molluscs (Cardot and Fellman, 1983; Schot et 
al, 1984; Elekes and Nassel, 1990; Fujiwara 
et al f 1991), insects (Carroll et al, 1986; Wather and 
Schafer, 1988; Robb and Evans, 1990; Sivasubramanian,
1991), coelenterates (Grimmelikhuijzen and Spencer,
1984; Carlberg et al. 1989; Koizani et al. 1989), 
crustaceans (Calloway et al . 1987; Mercier et al, i
1991), flatworms (Reuter et al. 1984), nematodes 
(Davenport et a l . 1988) and vertebrates (Sasek and 
Eide, 1985; Muske et al. 1987; Ostholm et al, 1990;
Kivipelto and Panula, 1990; Chiba et al. 1991). The 
more direct approach of isolation and characterization 
has revealed a variety of neuropeptides which are 
likely to be FMRFamide related. These have been found 
in a number of different animals, some of which are 
listed along with the neuropeptides in Table 1.1.
Table 1.1
À list of FMRFamide related peptides which have 
been isolated and characterized from a variety of 
animals.
Arthropods
(a) locust :Pro-Asp-Val-Asp-His-Val-Phe-Leu“Arg-Phe-NH2  (schisto FLRFamide)
(b) cockroach :pGlu-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2  (leucorayosuppressin)
(c) lobster ;Thr-Asn-Arg-Asn-Phe-Leu-Arg-Phe-NH2 (F^)
Ser-Asp-Arg-Asn-Phe-Leu-Arg-Phe-NH2 (F 2 )
(d) drosophila :Asp-Pro-Lys-Gln-Asp-Phe-Met-Arg-Phe-NH2
Coelenterates
(e) jellyfish :Glu-Leu-Leu-Gly-Gly-Arg-Phe-NH2(Pol-RFamide)
(f) sea anemone :pGlu-Gly-Gly-Arg-Phe-NH2 (Antho-RFamide)
Vertebrates
(g) chicken ;Leu-Pro-Leu-Arg-Phe-NH2
(h) oxen :Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2
Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2
References
(a) Robb et a l . 1989? (b) Holman et al. 1986?
(c) Kravitz et al, 1987 (F^)? Trimmer et al, 1987 (F2 );
(d) Nambu et al. 1988; (e) Grimmelikhuijzen et al,
1988; (f) Grimmelikhuijzen and Graff, 1986; (g) Dockray 
et al, 1983; (h) Yang et al, 1985.
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1.6.4 FMRFamide RELATED PEPTIDES OF HELIX
J
In 1981 Cottrell, Price and Greenberg analysed 
whole ganglia extracts from Helix aspersa for 
FMRFamide-like activity. They used chromatographic 
methods along with bioassays which were Busycon radula 
protractor muscle, Mercenaria heart and Helix heart.
When pooled ganglia extacts were chromatographed with 
FMRFamide, the biological activities did not elute from i
the column at the same time. Also, the relative potency 
of the purified peptide compared to FMRFamide on the
: ‘i
Busycon muscle and Mercenaria heart was about the same, 
but on the Helix heart was 600 times more potent.
Although FMRFamide-like activity originating from the 
ganglia had clearly been shown, this activity did not 
appear to be due to the action of authentic FMRFamide.
Purified extracts of the identified FI neurone were 
also shown to have FMRFamide-like activity.
Price et al. (1985) screened extracts of Helix 
ganglia for FMRFamide related peptides. Several peaks 
of FMRFamide-like immunoreactivity eluted from a HPLC 
column. One of these peaks co-eluted with oxidized 
FMRFamide and another with FMRFamide itself. This was 
evidence that authentic FMRFamide is present in Helix 
ganglia. The peptide purified and sequenced in this 
study was pGlu-Asp-Pro-Phe-Leu-Arg-Phe-NH2 
(pQDPFLRFamide), a FMRFamide related heptapeptide. This 
heptapeptide was 100 times more potent then FMRFamide 
on isolated Helix heart but slightly less potent on the 
Busvcon radula protractor muscle.
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Lehman and Price, (1987) looked at the 
localization of FMRFamide related peptides in different 
tissues of Helix aspersa. They found FMRFamide-like 
activity concentrated in the nervous system, male 
reproductive tract, tentacles and posterior digestive 
system. Immunohistochemical investigations confirmed 
these localizations. When the tissue extracts were 
analysed by gel chromatography, HPLC and bioassay, they 
were found to contain both FMRFamide and the extended 
heptapeptide pQDPFLRFamide.
More recently. Price et al (1990) have identified 
seven FMRFamide related peptides in both whole Helix 
aspersa and isolated ganglia. A list of these 
neuropeptides is given Table 1.2 showing their amino 
acid sequences and single letter abbreviations. When 
bioassayed on Helix heart the heptapeptides were more 
potent than the tetrapeptides.
A system thought to be ideal for studying 
FMRFamide as a neurotransmitter substance was 
investigated by Cottrell et al (1983). An identified 
neurone in each cerebral ganglion of Helix aspersa, the 
C3, stained positively with antisera for FMRFamide.
When the C3 neurones were subjected to RIA, the results 
confirmed the presence of FMRFamide-like activity. The 
processes of the C3 neurones were traced in the ganglia 
and associated nerve trunks. Several branches passed 
along to the tentacle retractor muscle. Stimulation of 
the C3 neurone evoked a smooth contraction of the 
muscle while exogenously applied FMRFamide produced 
rhythmic rather than smooth muscle contractions.
Table 1.2
The FMRFamide related peptides of Helix aspersa 
The single letter abbreviations for the amino acid 
sequences of the neuropeptides are shown.
Phe-Met-Arg-Phe-NH g 
F M R F amide
Phe-Leu“Arg-Phe-NH2  
F L R F amide
pGlu-Àsp-Pro-Phe-Leu-Arg-Phe-NH2  
pQ D P F L R F amide
Asïi-Asp-Pro“Phe-Leu-Arg-Phe-NH2 
N D P F L R F amide
Ser-Asp-Pro-Phe-Leu-Arg-Phe-NH2  
S D P F L R F amide
Asn-Asp-Pro-Tyr-Leu-Arg-Phe-NH2 |
N D P Y L R F amide I
Ser-Glu-Pro-Tyr~Leu-Arg-Phe-NH2 
S E P Y L R F amide
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Exogenously applied ACh, although 100 times less potent 
than FMRFamide, evoked a smooth contraction.
Xu et a l . (1989) demonstrated that the C3 neurone 
contained ACh along with the target muscle and could 
produce ACh from its usual precursors. Bewick et al,
(1990) found that FMRFamide was the only FMRFamide 
related peptide present in the C3 neurone. Using 
intracellular recording methods ACh was shown to evoke 
depolarization of the muscle fibres whilst FMRFamide 
had no effect on membrane potential. Therefore, 
although FMRFamide has been positively identified in 
the C3 neurone, its role in this system remains to be ^
elucidated.
1.6,5 FMRFamide RELATED PEPTIDES OF LYMNEA AND APLYSIA
Members of the FMRFamide related family of 
neuropeptides in Helix are by no means confined to this 
molluscan species. For example, in ganglia of the snail 
Lymnea staanalis FMRFamide, SDPFLRFamide and 
GDPFLRFamide (see Table 1.2 for amino acid sequences) 
have been identified (Ebberink et al. 1987). FMRFamide 
has been purified and sequenced in ganglia of Aplysia 
(Lehman et al. 1984) and the precursor protein for 
FMRFamide has been found in Aplysia (Scheller and Kirk,
1987). It contains 28 copies of FMRFamide and 1 copy of 
FLRFamide.
Indirect evidence was presented by Schacher et a l .
(1985) that FMRFamide might be released from an Aplysia 
neurone which is known to be cholinergic. The giant
" if
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cholinergic R2 neurone was cultured with the Lll and 
R15 neurones from the abdominal ganglion. The Lll and 
R15 neurones receive a cholinergic input from other 
neurones in vivo, but not from the R2. When in culture, 
the R2 reliably formed unidirectional chemical 
connections with these neurones. The connection between 
the R2 and Lll neurones had both a fast inhibitory and 
a slow excitatory component. The former effect was 
shown to be cholinergic but the latter was not. This 
indicated that the slow excitatory réponse was evoked 
by a non-cholinergic transmitter. A similar situation 
arose with the R2-R15 connection. Action potentials in 
the R2 neurone produced a slow inhibitory réponse in 
the R15 neurone, an effect which was not cholinergic. 
The fast excitatory response normally observed for 
cholinergic input onto the R15 neurone in the intact 
ganglion was not seen. The R15 in culture did have 
cholinergic receptors since ACh application evoked a 
fast excitatory response of this neurone. Thus the R2 
must also have been releasing a non-cholinergic 
transmitter onto the R15 neurone.
Previous reports had shown that the R2 neurone 
contained immunoreactivity for FMRFamide (Brown et al, 
1984) and that this neuropeptide was able to produce 
both inhibitory and excitatory actions on abdominal 
ganglion neurones (Stone and Mayeri, 1981). It seemed 
that FMRFamide was therefore a strong candidate for the 
non-cholinergic transmitter released by the R2 neurone.
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1.6.6 EXPRESSION OF FMRFAMIDE RELATED PEPTIDES IN 
LYMNEA AND HELIX
In Lymnea it has been shown by Linacre et al,
(1990) that a single gene encodes for a precursor 
protein which contains 9 copies of FMRFamide, 2 copies 
of FLRFamide and 2 putative pentapeptides, Glu-Phe-Leu- 
Arg-Ile-NH2 (EFLRIamide) and pGlu-Phe-Tyr-Arg-Ile-NH2 
(pQFYRIamide). Saunders et al, (1991) found that an 
exon 3' to the FMRFamide/FLRFamide encoding region 
encoded 7 copies of GDPFLRFamide and 6  copies of 
SDPFLRFamide. Another 3 peptides encoded by this exon 
were Glu-Phe-Phe-Pro-Leu-NH2 (EFFPLamide), 
spPYFLRFamide and Ser-Asp-Pro-Phe-Phe-Arg-Phe-NH2 
(SDPFFRFamide). The conclusion reached was that the 
region encoding the extended peptides makes up one exon 
of an extended gene. Preliminary analysis also showed 
that GDP-/SDP-FLRFamide mRNA was expressed in discrete 
neurones in the CNS. It is possible that some neurones 
may express only extended peptides and others only 
tetrapeptides.
Two copy DNA (cDNA) clones encoding the FMRFamide i
related peptides have been isolated from Helix aspersa 
ganglia (Lutz et al, 1991). They were named HFl and 
HF4. On the HFl message there are 10 copies of 
FMRFamide and 1 copy of FLRFamide. The HF4 cDNA clone 
encodes the extended peptides and some novel peptides.
It remains to be determined whether the regions 
encoding the tetrapeptides and the extended peptides 
are located on 1 gene or 2 separate genes, but it is
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clear that there are different species of mRNA and that 
each is differentially expressed in different neurones.
1.6.7 FMRFamide RELATED PEPTIDES OF HELISOMA
The CNS of the pond snail Helisoma has been shown 
to contain FMRFamide, FLRFamide and GDPFLRFamide 
(Bulloch et al, 1988).
Richmond et al . (1991) have found that the 
peptidergic synapse formed between the identified 
central neurones of Helisoma. VD4 and its target PI, 
has proved to be an ideal system with which to examine 
the release and postsynaptic effects of FMRFamide 
related peptides. The VD4 neurone was shown to contain 
FMRFamide along with smaller amounts of FLRFamide and 
GDPFLRFamide. The action of these neuropeptides were 
examined on the postsynaptic PI neurone in culture 
conditions. FMRFamide and FLRFamide reduced the 
macroscopic high-voltage-activated (HVA) Ca2+ current 
while GDPFLRFamide had only small effects at higher 
concentrations. The reduction of the Ca2+ current by 
FMRFamide was found to be irreversible in the presence 
of GTPfS, a non-hydrolysable analogue of GTP. This 
indicated that these FMRFamide related peptides acted 
through receptor coupled G proteins to reduce the HVA %
Ca2 + current.
The synaptic connection between VD4 and PI was 
simulated in culture. Fura-2 was used to monitor the 
action potential evoked Ca^^ transient in neurites 
growing from PI neurones. Applications of FMRFamide,
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FLRFamide and GDPFLRFamide all reduced the magnitude of 
this transient. This action of the neuropeptides was 
mimicked by stimulation of the VD4 presynaptic neurone. 
There were also localized reductions in the action 
potental evoked Ca2+ transients in the PI neurone at 
the points of contact between the neurites of VD4 and 
PI. These results indicated that FMRFamide related 
peptides released from VD4 neurones reduced the Ca^^ 
influx of neurone PI.
Stimulation of VD4, as well as reducing Ca^^ 
influx in the PI neurone also reduced the excitability 
of the PI. Initial experiments by Richmond 
(unpublished) indicated that this was due to an 
increased conductance. Although this effect remains 
to be characterized, it seems likely that the FMRFamide 
related peptides from the VD4 neurone hyperpolarize the 
PI neurone by increasing a conductance.
1.6.8 FMRFamide RELATED PEPTIDES IN VERTEBRATES
The FMRFamide related peptides which have been 
isolated and sequenced from vertebrate animals are 
listed in Table 1.1. The pentapeptide Leu-Pro-Leu-Arg- 
Phe-NH2 (LPLRFamide) which was identified in chicken 
brain (Dockray et al. 1983) proved to be the first 
vertebrate peptide to have been discovered by its 
interaction with an antiserum to an invertebrate 
neuropeptide. Biological activity of this neuropeptide 
was examined on two systems and compared to FMRFamide. 
Intravenous injection of the pentapeptide into
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anaesthetized rats produced a rapid increase in 
arterial blood pressure which had a similar time course 
to that of FMRFamide. The peak increase in arterial 
blood pressure was also similar to the FMRFamide 
effect. The pentapeptide was tested on rat brain stem 
neurones. Depending on which area of the brain stem the 
pentapeptide was applied to, its action was either 
inhibitory or exitatory. Its actions on these neurones 
corresponded to those of FMRFamide.
Two FMRFamide related peptides have been 
structurally characterized by Yang et al. (1985) from 
bovine brain extracts, one an octapeptide and the other 
an octadecapeptide. These bovine neuropeptides, along 
with the chicken brain pentapeptide were tested in a I
RIÀ and two standard bioassays (Greenberg et al. 1988).
The effects were relatively weak but nevertheless 
similar to those of FMRFamide. The chicken brain 
pentapeptide was the most potent of the three. This was 
not surprising since it had the closest structural 
similarity to FMRFamide.
1.6.9 RELEASE OF FMRFamide RELATED PEPTIDES
Studies of neuropeptide release from invertebrate 
neurones is difficult because of the small amounts 
involved. However, as has been shown with Helisoma 
important results are now forthcoming.
Release of FMRFamide from Macrocal1ista ganglia 
was detected using RIA by Nagle, (1982). It occured
3:
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upon depolarizing the preparation with a high 
containing saline and was Ca^t dependent.
FMRFamide-like immunoreactive release from 
neurohaemal organs of the moth Manduca sexta was 
analysed by Carroll et al . (1986). When these organs 
were placed in normal saline there was a basal release. 
This was doubled in the presence of a high Ca^^ 
containing saline. Little FMRFamide immunoreactivity 
was released in a high K"*", Ca^^ free saline. It was 
therefore dependent upon depolarization and the 
presence of Ca^^.
FMRFamide-like immunoreactive release from Helix 
ganglia was shown to occur by exposing the preparation 
to a high containing saline (Lesser et al . 1989). It 
was also dependent on Ca^^ levels.
1.7 ACTIONS AND ROLES OF FMRFamide RELATED PEPTIDES
ON MOLLUSCAN NEURONES
The large, readily identifiable neurones found in 
the nervous systems of certain molluscan species have 
been utilized to great effect in studies of the actions 
and roles of the FMRFamide related peptides in nervous 
tissue. Examples of such studies under the headings of 
the species used and currents examined are given below. 
In some cases the intracellular mechanisms underlying 
the actions of these neuropeptides have been 
elucidated. A summary of the details given in this 
section are shown in Table 1.3.
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1.7.1 HELIX
Cottrell et a l . (1984) and Cottrell and Davies 
(1987) tested the effects of FMRFamide and some related 
peptides on identified neurones of Helix aspersa. Some 
were hyperpolarized and others depolarized. A 
combination of these two effects occured in some 
neurones.
1.7.1.1 SLOW HYPERP0LARI2ING K+ CURRENT (SLOW IK+)
FMRFamide application to the Cl neurone of each 
cerebal ganglion and several suboesophageal ganglia 
neurones induced a hyperpolarizing response which 
involved an increase in membrane conductance. The 
response did not desensitize with repeated applications 
and the reversal potential (-70 to -75mV) indicated 
that it might be due to the production of an outward K+ 
current. This was confirmed by ion substitution 
experiments and the reduction of the response by 
channel blockers such as tetraethylammonium (TEA) and 
intracellular cesium ions (Cs"*"). FLRFamide and the 
synthetic tetrapeptide Phe-Ile-Arg-Phe-NH2 (FIRFamide) 
both induced a similar response in the Cl neurone 
although FIRFamide was slightly less potent. The 
implication was that all three neuropeptides acted on 
the same receptor.
%3 1
1.7.1.2 FAST HYPERPOLARIZING K+ CURRENT fFAST IK+1
The synthetic heptapeptide Tyr-Gly-Gly-Phe-Met- 
Arg-Phe-NHg (YGGFMRFamide) and pQDPFLFRamide 
hyperpolarized a number of identified neurones which 
included F76, F77. This response did not desensitize 
with repeated applications. It was found to be due to 
the production of an outward K"*" current by the same 
means used to study the slow current. The response 
induced by the heptapeptides was considerably faster 
than that of tetrapeptides, hence the terms "fast" and 
"slow". The fast response was not observed on the Cl 
neurone and application of high concentrations of the 
heptapeptides induced only a slow K"^  current. The 
differences between the fast and slow responses 
suggested that they may have been due to the activation 
of two different receptors.
1.7.1.3 DEPOLARIZING. VOLTAGE DEPENDENT DECREASE 
OF A K+ CURRENT (DECREASED IK+ fvU
When the Cl neurone was held at potentials between 
-40 and -20mV, FMRFamide induced a biphasic response 
which was comprised of an outward slow current and 
an inward current (Cottrell, 1982). Depolarizing the 
neurone even further allowed the inward current to 
predominate. YGGFMRFamide and pQDPFLRFamide were more 
potent than the tetrapeptides at producing the effect 
(Cottrell et al, 1984). This current was found to be
‘1
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due to the reduction of an outward K"^  current which 
showed some Ca^^ dependency.
Single channel recordings using cell attached 
patches showed that application of FnLRFamide (a 
synthetic FMRFamide analogue) or YGGFMRFamide reduced 
the number of channel openings in a depolarized patch 
(Cottrell et al. 1984). The channels closed were K+ 
channels. The neuropeptides had no direct access to the 
patch of membrane under investigation. Therefore, the 
neuropeptide would have had to generate an 
intracellular second messenger in order to influence 
the activity of the patch.
5-HT application to the depolarized Cl neurone 
also reduces an outward K"*" current. It was shown that 
5-HT and the FMRFamide related peptides might operate 
on the same K’^ channels since FMRFamide had no effect 
in the presence of 5-HT (Davies, 1986). Studies of the 
intracellular events which underlie the effect of 5-HT 
have indicated that protein kinase C activation and 
protein phosphorylation are involved (Hill-Venning and 
Cottrell, 1988; Cohen et al. 1989).
1.7.1.4 FAST DEPOLARIZING Na+ CURRENT (FAST INa+)
FMRFamide application to the El3 neurone of the 
visceral ganglion induced a fast depolarization which 
desensitized rapidly. This depolarization was due to 
the influx of Na^. The heptapeptides pQDPFLRFamide and 
YGGFMRFamide were unable to produce a response 
(Cottrell and Davies, 1987).
33
Recently, this response has been studied in more 
detail by Cottrell et al  ^ (1990). The F2 and C2 
neurones also responded to FMRFamide with a fast Na^ " 
inward current. Combined data from the F2 and C2 
neurones were presented. The response in the F2 neurone 
was unaffected by lOO^M tubocurarine which at this 
concentration effectively abolishes the fast 
depolarizing responses to ACh, dopamine, histamine, 
aspartate and glutamate in molluscan neurones 
(Carpenter et al. 1977). When FMRFamide was applied to 
outside out patches exised from isolated or in situ C2 
neurone cell bodies, small unitary currents were 
observed at negative potentials. Often more than one 
channel was observed which indicated that the FMRFamide 
receptors are clustered. Less than 10% of the patches 
obtained responded to FMRFamide suggesting a sparse 
distribution of receptors. The réponse current/voltage 
relationship of these unitary currents was in agreement 
with a pure Na"^  conductance. The unitary currents were 
still seen when the patches had been isolated for 2 0  
minutes which indicated that a second messenger was not 
required for the response. This is the first known 
example of a neuropeptide directly activating a ligand 
gated ion channel.
1.7.1.5 RECEPTORS
Cottrell and Davies (1987) interpreted these four 
responses of the FMRFamide related peptides in terms of 
the activation of four different receptor types. They
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found that the C-terminal amino acid sequence of Phe- 
Met (or Leu)-Arg-Phe-NH2 was required by these 
receptors for them to be activated. Analogues with 
amino acid substitutions in any of these positions or 
the amide group removed had no effect on the Helix 
neurones tested.
1.7.1.6 RELATED STUDIES ON K+ AND Na+ CURRENTS
Boyd and Walker (1985; 1987) also examined the 
actions of FMRFamide related peptides on identified 
Helix neurones. Their results generally corresponded 
with Cottrell's group. FMRFamide and FLRFamide induced 
hyperpolarizing outward currents and depolarizing 
inward Na"^  currents, although FLRFamide was much less 
potent, pQDPFLRFamide hyperpolarized neurones with 
varying potencies but did not produce excitation in any 
of the neurones tested. FMRFamide and pQDPFLRFamide 
were both quoted as hyperpolarizing the E13 neurone. 
This was contrary to the findings of Cottrell's group 
who report that FMRFamide depolarized the E13 neurone 
and pQDPFLRFamide had no effect.
1.7.1.7 Ca2+ CURRENTS rDECREASED ICa2+fv1 
INCREASED ICa^+TvU
In two identified Helix aspersa neurones, D3 and 
E2, FMRFamide decreased the duration of the Ca^^ action 
potential (Colombaioni et al. 1985). In another 
neurone, the Ell, FMRFamide decreased Ca^^ conductance.
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the amplitude of the Ca^’*' spike plateau and a cyclic 
AMP dependent K"*" conductance known as the "S" K+ 
current.
The effects of FMRFamide related peptides on a 
Ca2+ current of the Cl neurone were studied by Cottrell 
and Lesser, (1987). FMRFamide and FLRFamide reversibly 
reduced the total inward Ca^+ current by 30%. 
pQDPFLRFamide and YGGFMRFamide had no consistent 
inhibitory effect on the current. The fact that the 
tetrapeptides had an effect whilst the N-terminally 
extended heptapeptides did not, is a similar situation 
to that described with the fast Na"** current (Cottrell 
and Davies, 1987).
It has been shown by Yakel, (1991) that FMRFamide 
can both inhibit and enhance the Ca^^ current in 
cultured Helix central neurones via independent 
mechanisms. The inhibition usually involved a decrease 
in amplitude and rate of inactivation of the current. 
Pertussis toxin (an inhibitor of G^ and Gq proteins) 
produced a time dependent block of both the FMRFamide 
induced decrease in amplitude and decrease in the rate 
of inactivation of the Ca^^ current. The irreversible 
activation of G proteins by GTP*S did not reduce the 
amplitude of the current but did reduce the 
inactivation rate, the latter effect being a mimic of 
the FMRFamide response. There was no evidence to 
indicate that any of the commonly known second 
messenger systems were involved. These results 
suggested that the inhibition of the Ca2 + current may 
have been due to a direct coupling between the
,i
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FMRFamide receptors and Ca^^ channels through a 
pertussis toxin sensitive G protein. The FMRFamide 
induced enhancement of the Ca^^ current reduced with 
time and the inclusion of NAD+ in the patch electrode 
filling solution, diminished this effect, suggesting 
that a NAD+ dependent intracellular mechanism could 
modulate the response. Ca^^ current enhancement was not 
associated with changes in the rate of activation or 
inactivation. The enhancement does not appear to 
involve a pertussis toxin sensitive G protein.
1.7.2 APLYSIA
1.7.2.1 K+ CURRENTS (INCREASED IK+ fs))
FMRFamide and 5-HT have opposing effects on the 
electrical excitablity of Aplysia sensory neurones and 
on transmitter release from sensory neurone presynaptic 
terminals (Siegelbaum et al. 1982; Belardetti et al. 
1987). These effects could be termed as modulatory. 
FMRFamide produced an increase in probability that a K"*" 
channel known as an "S" channel is opened. This 
results in a slow, inhibitory hyperpolarization and a 
decrease in action potential duration which contributes 
to presynaptic inhibition. In contrast, 5-HT produced 
prolonged, all or nothing closure of the "S" K"*" 
channels by acting through cyclic AMP dependent protein 
phosphorylation. This results in a slow depolarization 
and an increase in the duration of the action potential 
which contributes to presynaptic facilitation.
3 7
Furthermore, FMRFamide could override the exitatory 
action of 5-HT at the single channel level so that 
FMRFamide reopens "S" K"^  channels closed by 5-HT or 
cyclic AMP.
A number of studies were performed in an attempt 
to elucidate the intracellular mechanisms underlying 
these actions of FMRFamide (Piomelli et al, 1987).
Application of arachidonic acid to sensory neurones 
mimicked the effects of FMRFamide. The 12-lipoxygenase 
metabolite of arachidonic acid, 1 2 -hydroperoxyeicosate- 
traenoic acid (12-HPETE), also mimicked the action of
FMRFamide. It was thought that this metabolite of
arachidonic acid was produced intracellularly leading 
to the opening of the "S" K"*" channels. However, the 
situation is complicated in that 12-HPETE could 
directly modulate "S" channels when applied to the 
outside membrane of outside out patches (Buttner et al.
1989). There is a possiblity that this metabolite can 
interact with a site on the channel protein near the
outer surface of the membrane.
Volterra and Siegelbaum, (1988) looked at how the 
action of FMRFamide on these neurones could be linked 
to the production of arachidonic acid. Using activators 
and inhibitors of G proteins they concluded that a 
pertussis toxin sensitive G protein was most likely to 
couple the FMRFamide receptor to phospholipase 
activation and arachidonic acid production.
Sweatt et al . (1989) examined the combined effects 
of FMRFamide and 5-HT on protein phosphorylation of 
these neurones. FMRFamide decreased the levels of i
.   _
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protein phosphorylation without altering the level of 
cyclic AMP. FMRFamide also overrode the cyclic AMP 
mediated enhancement of transmitter release produced by 
5-HT and reversed the cyclic AMP dependent increase in 
protein phosphorylation produced by 5-HT. It was 
unclear whether the reduction of protein 
phosphorylation was caused by protein kinase inhibition 
or phosphatase activation.
Ichinose and Byrne (1991) looked at the role of |
Iprotein phosphatases in the opening and closure of "S" :
1K"*" channels by FMRFamide and 5-HT. The protein |
phosphatase 1 and 2A inhibitor, okadaic acid, and |
purified protein phosphatase enzymes were used. They I
found that in the absence of physiological stimulation, |Ibasal levels of phosphorylation regulated the channel. |
The FMRFamide, 5-HT and cyclic AMP induced responses i
were regulated by protein phosphatases and the
FMRFamide induced outward "S" K'*" current may be partly i1due to the activation of protein phosphatases.
1In a recent study by Shi and Belardetti, ,
(1991) the effects of 5-HT, cyclic AMP and FMRFamide on i
sensory neurones were examined in detail. They found ;j
that application of lOO^M FMRFamide in the presence of 
membrane soluble 8 -bromo cyclic AMP resulted in an 
outward current larger than the control FMRFamide 
response and equal to the sum of 8 -bromo cyclic AMP and 
FMRFamide alone. When FMRFamide was applied at 500/uM it 
completely antagonized the closing actions of maximal '
8 -bromo cyclic AMP (lOO^M). This confirmed in these 
neurones that FMRFamide can open "S" K"*“ channels closed
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by cyclic AMP. However, with moderate concentrations of 
5-HT, which produce a slow inward current due to 
c l o s u r e s  of the "S" K"*" channels, FMRFamide could only 
partially antagonize this action. At maximal 5-HT 
concentations (O.l^M) 5-HT response was not antagonized 
by any FMRFamide concentration and FMRFamide responses 
were smaller than control. These results indicated that 
5-HT could inhibit the FMRFamide response by a cyclic 
AMP-independent mechanism. They also confirmed that 
FMRFamide responses could be mimicked by the 
application of arachidonic acid.
Brezina et al, (1987a) found that FMRFamide and 
YGGFMRFamide were equally effective in activating an 
outward K"^  current in abdominal ganglion neurones of 
Aplysia (R2, L2 , L3, L4, and L6 ). The current was 
independent of voltage and Ca^t levels. It was blocked 
by 5-HT and raised cyclic AMP levels. Patch clamp 
studies showed that channel activity was reduced by 5- 
HT and enhanced by FMRFamide. The evidence indicated 
that this was a ”S" K**" current. Brezina, (1988) later 
found that GTPfS and ACh activated outward K"** currents 
which were identical to the FMRFamide induced current.
It was thought that FMRFamide and ACh, acting through 
different receptors, activated the same current by a 
mechanism involving a G protein.
FMRFamide has also been shown to have effects on 
the duration of action potentials, excitability and 
membrane currents in tail sensory neurones of Aplysia 5
(Critz et al, 1991). Whereas 5-HT increased the 
duration of action potentials and caused an enhancement
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of excitability in cell bodies of tail sensory 
neurones, FMRFamide reversed these actions and 
decreased the duration of excitability and action 
potentials. It was found that FMRFamide had actions on 
three K"^  currents. One current which was increased by 
FMRFamide had properties indicating it was an "S" 
current. Another current reduced by FMRFamide was a 
Ca2+ dependent K"*" current, A third current increased by 
FMRFamide with large depolarizations appeared to be a 
delayed or voltage dependent current. Extracellular 
application of arachidonic acid mimicked the action of 
FMRFamide on the three currents which indicated that 
this second messenger may be underlying these effects.
1.7. 2. 2 Na+ CURRENTS flNa+ fvU
Ichinose and McAdoo, (1988) characterized the 
effects of FMRFamide on the R14 abdominal ganglion 
neurone of Aplysia californica and Aplysia brasilina.
FMRFamide induced a fast outward current, a fast inward 
current and a slow inward current. The slow inward 
current was examined in detail. It was carried mainly 
by Na"^  and exhibited voltage dependency. The largest 
amplitude occured between -40 and -20mV. The amplitude 
of the current was independent of external K"^  but did 
increase when external Ca2+ and Cl“ concentrations were 
reduced. The current also desensitized upon successive 
applications of FMRFamide.
Icinose and McAdoo, (1989) discovered that by 
injecting cyclic GMP into the R14 neurone they could i
■'"i
"1
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mimic the FMRFamide response. The cyclic GMP current 
had the same characteristics of the FMRFamide response 
described above. Phosphodiesterase inhibitors which 
prevent the metabolism of cyclic nucleotides increased 
the cyclic GMP and FMRFamide induced inward current. 
These results indicated that FMRFamide opens the Na"*" 
channels by activating the cyclic GMP intracellular 
second messenger system.
1.7.2.3 Ca2+ CURRENTS (DECREASED ICa^+rvU
Brezina et a l  ^ (1987b) showed that FMRFamide and 
YGGFMRFamide were equally effective in suppressing a 
pharmacologically isolated Ca^^ current in abdominal 
ganglion neurones (R2, R15, L2, L3, L4 and L 6 ) of 
Aplysia. This suppression was incomplete suggesting 
that more than one class of Ca2 + channel was present 
only, one of which was neuropeptide sensitive. The rate 
of activation and inactivation of the remaining Ca^*^ 
current was unaffected. The intracellular second 
messenger systems involving cyclic AMP, cyclic GMP, 
Ca2+, IP3 and protein kinase C activation did not 
appear to be involved in the suppression. The 
suppression did seem to be mediated by the same 
receptor as that causing the outward "S" K"^  current.
The Ca2+ current effect and the ”S” K"*" current were 
both mimicked by GTPfS injection implicating the 
involvement of G proteins.
1
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1.7.2.4 Cl“ CURRENTS fICl~fvn
When FMRFamide was applied to the L2 abdominal 
ganglion neuron of Aolysia. it activated an inwardly 
rectifying current and reduced the amplitude of the 
transient K"^  current (Thomson and Ruben, 1988). The 
reversal potential of the inward rectifier tended to be 
variable but was near -40mV at the start of 
experiments. The current was voltage dependent. Changes 
in external Na+, Ca^ "*", or concentrations had no 
effect but lowering the external Cl” concentration had 
complicated effects on the current amplitude. The 
current was also dependent on intracellular Cl” 
concentrations. It was concluded that the inward 
rectifier was a Cl“ current.
1.7.3 HELISOMA
The characteristics of the peptidergic synapse 
formed between the FMRFamide related peptide containing 
VD4 (presynaptic) and PI (postsynaptic) neurones have 
already been described in Section 1.6,7. Here attention 
will be drawn to studies performed by Man-Son-Hing e t  
al, (1989) and Haydon et alp (1991).
Man-Son-Hing et al, (1989) looked at the 
cholinergic chemical synapse formed in cell culture by ^
Helisoma neurones B5 and B19. It was possible to 
depolarize the B5 neurone to evoke transmitter release 
and record the postsynaptic currents in the B19 
neurone. When FMRFamide was applied, the number of
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depolarization evoked postsynaptic currents were 
reduced although the postsynaptic sensitivity to ACh 
was unaffected. Therefore FMRFamide was probably 
causing presynaptic inhibition of ACh release from the 
B5 neurone.
By voltage clamping the B5 neurone they found that 
FMRFamide reduced the magnitude of the high voltage 
activated Ca^^ (decreased ICa^‘^ (v)) current which 
raises intracellular Ca^+ and triggers ACh release. The 
Ca2+ dependent secretory apparatus of the B5 neurone 
was also examined. The elevation of intracellular Ca^^ 
levels to evoke transmitter release was achieved by 
injecting the photolabile Ca^^ cage, nitr-5. This 
dissociated the voltage dependent current from the Ca^^ 
dependent secretory event and in a sense was a Ca^^ 
clamp. Exposure to ultraviolet light released Ca%+ from 
the cage and this increased the rate of postsynaptic 
currents in the B19 neurone which was due to ACh 
release. FMRFamide application reversibly reduced the 4
rate of the postsynaptic current. The level of free 
Ca2+ in the B5 neurone was unaffected by FMRFamide.
Therefore, the suggestion was that FMRFamide somehow 
reduced the sensitivity of the secretory apparatus to 
elevated internal Ca^^. This was the first report of 
such an effect of FMRFamide or any other neuropeptide 
on neurones.
In a more recent study by Haydon et al, (1991), it 
was found that FMRFamide modulation of secretory 
machinery underlying presynaptic inhibition of synaptic 
transmission in cultured Helisoma neurones, requires a
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pertussis toxin sensitive G protein. The synapse 
examined was again that between neurones B5 and B19. 
Neurotransmitter release at the cultured synapses was 
found to be quantal in nature. FMRFamide application 
reduced the frequency of miniature inhibitory 
postsynaptic currents (MIPSCs) without affecting free 
intracellular Ca^^ concentration. GTPfS injection into 
the presynaptic neurone mimicked the effect of 
FMRFamide. When pre-activated pertussis toxin was 
injected into the presynaptic neurone, FMRFamide was 
unable to reduce either MIPSC freqency or the magnitude 
of action potential evoked inhibitory postsynaptic 
currents. It was found that concentrations of less than 
10”?M FMRFamide was able to modulate the secretory 
machinery, a concentration that does not effect Ca^^ 
current amplitude.
1.8 AIMS AND OBJECTIVES
The examples quoted show that neuropeptides 
influence a variety of ionic currents in both 
vertebrate and invertebrate neurones. The general 
procedure has been to characterize these actions 
electrophysiologically and pharmacologically at the 
outset and then attempt to understand the mechanisms 
involved in coupling the receptors to the ion channels. 
A combination of these approaches have been used in the 
work presented in this thesis to examine two currents 
induced by FMRFamide in identified neurones of Helix 
aspersa. The aims were: 1) to elucidate the
Table 1.3
Summary of the FMRFamide related pepide effects on 
molluscan neurones described in the text. The 
mechanisms of action of the neuropeptides are listed 
where appropriate.
Slow IK+
Fast IK+
Decreased IK+(v)
IK+(s)
IK+(s)
IK+(s)
IK+(Ca2+)
IK+(v)
Fast INa+
INa+(v)
Decreased ICa^+fv) 
Decreased ICa^+fv)
Decreased ICa^+fv)
Helix Cl neurone. FMRFamide, FLRFamide more potent than FIRFamide. Mechanism studied in this thesis.
Helix F76, F77 neurones. pQDPFLRFamide, YGGFMRFamide. Mechanism unknown.
Helix Cl neurone. pQDPFLRFamide, YGGFMRFamide more potent than FMRFamide. 5-HT has same effect by activating protein kinase C
Aplysia sensory neurones. FMRFamide. Mechanism through PTX sensitive G protein, lipoxygenase metabolites of arachidonic acid. Protein phosphorylation involved.
Aplysia R2, L2, L3, L4 and L 6  neurones. FMRFamide, YGGFMRFamide. Mechanism involves a G protein.
Aplysia tail sensory neurones. FMRFamide. Arachidonic acid involved.
Aplysia tail sensory neurones. FMRFamide. Arachidonic acid involved.
Aplysia tail sensory neurones. FMRFamide. Arachidonic acid involved.
Helix C2, F2 and E13 neurones. FMRFamide. Mechanism is a ligand gated ion channel.
Aplysia R14 neurone. FMRFamide. Mechanism through cyclic GMP pathway.
Helix Cl, D3 and E2 neurones. FMRFamide, FLRFamide. Mechanism unknown.
Aplysia R2, R15, L2, L3 , L4 and L 6 neurones. FMRFamide, YGGFMRFamide Mechanism through a G protein. Not through cyclic AMP, cyclic GMP,IP3 or protein kinase C.Ca2+,
Helix cultured central neurones. FMRFamide. Mechanism: receptors coupled directly to a PTX sensitive G protein.
Decreased ICa^”**(v)
Increased ICa^+fv)
VD4 and PI neurones in culture. FMRFamide, FLRFamide and GDPFLRFamide. G protein activation involved. VD4 stimulation mimicked peptide action.
Helix cultured central neurones. FMRFamide. NAD^ dependent mechanism.
I
ICl“ (v) Aplysia L2 neurone. FMRFamide. Mechanism unknown.
* Unique effect Helisoma cultured B5 and B19 neurones. FMRFamide. Decreased Ca^^ sensitivity of secretory apparatus. Modulation of secretory apparatus through activation of pertussis toxin sensitive G protein.
J. .
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mechanism(s) underlying the FMRFamide slow current 
in the Cl neurone and 2) to begin to characterize the 
FMRFamide fast Na"^  current in the C2 neurone.
-'1 ^  i
Chapter 2 
Methods
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2.1 THE EXPERIMENTAL PREPARATION
2.1.1 ANIMAL MAINTENANCE
Helix aspersa were collected locally and upon 
arrival in the laboratory were in a state of 
hibernation. Inactive animals were activated by placing 
them in a shallow volume of warm water (30-35°C). Once 
activated, the animals were maintained in this state at 
room temperature (18-22°C) by placing them in a moist 
environment which consisted of damp tissue paper within 
a large, sealed, plastic container with air holes. This 
container also allowed sufficient light penetration.
Fresh lettuce leaves were provided as a food source.
2.1.2 DISSECTION
All experiments were performed on Cl and C2 
neurones of the cerebral ganglia.
An active snail was decapitated using scissors at 
a point shown in Figure 2.1 and the head pinned out on 
a wax dissecting board. One pin was inserted through 1
the mouth and another through the oesophagus. When the 
skin was cut and pulled back, the position of the 
circumoesophageal complex of ganglia (cerebral ganglia 
and suboesophageal ganglia) was revealed. This was 
removed from the animal and placed in a small Perspex 
bath (1ml) which was lined with a Sylgard base (Sylgard 
184 silicone elastomer, Dow Corning) and filled with 
normal Helix saline (80mM NaCl, 5mM KCl, 5mM MgCl2 , 7mM
>ï
cut
cerebral ganglia
buccal mass
subc^sophageal ganglia
oesophagus
Figure 2.1
Diagram showing where the head of an activated 
snail was decapitated and the relative positions of the 
cerebral and suboesophageal ganglia within the head.
The cerebral ganglia lie in the dorsal surface of the 
oesophagus and the subesophageal ganglia on the ventral 
surface,
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CaCl2 / 20mM Hepes, pH 7.5). From this point all 
manipulations of the tissue were carried out with the 
aid of a binocular dissecting microscope (Nikon) at 
magnifications ranging from x9 to x40. A tapered glass 
rod attached to a light source was placed close to the 
tissue inside the bath to illuminate the preparation.
The cerebral and suboesophageal ganglia were 
separated by cutting through the nerve connectives 
using fine dissecting scissors. The cerebral ganglia 
were pinned out on the Sylgard base with the ventral 
surface uppermost. The cell bodies of the neurones are 
normally covered with two layers of connective tissue. 
The outer layer was removed using two pairs of fine 
forceps. The inner layer of connective tissue is 
transparent, thin and very delicate. Great care was 
required to rupture this layer with forceps and expose 
the cell bodies of the individual neurones. The 
relative positions of the Cl and 02 neurones are shown 
in Figure 2.2. If the exposed neurones were required 
for patch clamping experiments, they were bathed in 
normal Helix saline containing 0.1% (w/v) trypsin 
(Sigma) for 15 minutes after which they were washed 
thoroughly with normal Helix saline. The enzyme trypsin 
was used to make it more suitable for high resistance 
seals to be obtained between the patch pipettes and 
neuronal cell membrane.
left cerebral ganglion
cerebral commisure
C2 neurone
C2 neurone
Cl neurones
inner lip nerve
Figure 2.2
A simplistic illustration of the cerebral ganglia 
as they were pinned out in the bath with the ventral 
surface uppermost. The relative positions of the Cl and 
0 2  neurones are shown.
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2.2 PERFUSION SYSTEM
An important requirement for most of the 
experiments was to have a perfusion system available. 
This meant that as well as being able to provide a 
constant flow of saline across the preparation, salines 
containing membrane soluble analogues of second 
messengers, enzyme activators, enzyme inhibitors and 
varying ionic concentrations could also be applied to 
the neurones.
The system consisted of various reservoirs (50ml 
syringes) connected to a multiwell tap via separate 
lines of soft plastic tubing. The outflow of the tap 
led to the small Perspex bath containing the 
preparation. By switching the tap to the appropriate 
reservoir, different salines could be brought into the 
perfusion stream. The driving force necessary to allow 
the perfusate to flow was provided in that the 
reservoirs were about 50cm above the level of the bath. 
The flow rates from the reservoirs were controlled by 
adjustable screw clamps on the soft plastic tubing. The 
flow rate was usually set at Iml/minute.
A suction system allowed the perfusate to be 
drained away from the bath. A suction tube made of 
plastic was connected to a collecting vessel (Buchner 
flask) via a drain line. The collecting vessel was 
attached to a small electric air pump which provided 
the vacuum required for suction. The suction tube was 
carefully positioned very close to, but just outside 
the bath. This ensured that as well as draining
'.V
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perfusate from the bath there was always a sufficient 
height of solution within the bath to cover the 
preparation.
2.3 INTRACELLULAR RECORDING METHODS
2.3.1 RECORDING ELECTRODES
Recording electrodes were fabricated from thin 
walled borosilicate glass capillary tubes with internal 
filaments (Clark Electromedical Instruments, type 
GC150TF-15). The significance of the internal filament 
was that the electrode tips could be filled quite 
simply by placing a small volume of recording 
electrolyte solution in the end of the electrode (back­
filling) . The solution was dragged down to the tip by 
capillary action along the filament.
Prior to pulling electrodes, the ends of the glass 
capillary tubes were rounded in a Bunsen burner flame. 
This prevented sharp edges on the ends of the 
electrodes scraping silver chloride (AgCl) from the 
AgCl coated silver recording wire. Electrodes were 
pulled on a Narashige PP-83 two stage vertical puller 
and stored in Petri dishes prior to use as a protection 
from dust. They were back-filled with a recording 
electolyte solution of 200mM KCl. The solution was 
delivered from a syringe and hypodermic needle 
incorporating a 0.22^m Millipore filter attachment. The 
electrodes when filled with this solution had a 
relatively low resistance, 1-2 Mn as measured by the
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impedance facility on the Dagan 8100 single electrode 
voltage clamp system. The low resistance was required 
for voltage clamping since the electrodes must be able 
to pass large amounts of current.
2.3.2 RECORDING APPARATUS
Intracellular recordings from neurones were made 
using a Dagan 8100 single electrode voltage clamp 
system. Both current and voltage clamping could be 
performed using a single electrode. Electrodes 
containing 200mM KCl, mounted on a Narashige 
micromanipulator were connected via a AgCl coated 
silver wire (Ag/AgCl) to the input of the Dagan 8100 
probe. Two methods were used to ground the bath 
containing the preparation. The first was to place a 
Ag/AgCl wire connected to the virtual ground of the 
Dagan 8100 probe into the saline solution bathing the 
preparation. The second involved the use of an agar 
bridge. This consisted of a glass tube filled with 3% 
(w/v) agar (BDH) made up in a IM KCl solution. One end 
was placed in the bath and the other in a small bottle 
containing a IM KCl solution. A Ag/AgCl wire, again 
connected to the virtual ground of the Dagan 8100 probe 
was placed in the IM KCl solution. The agar bridge was 
useful because when there was significant alterations 
in the ionic composition of the perfusing solution, the 
bridge minimised changes in junctional potentials. A 
diagram showing the relative positions of this 
equipment is provided in Figure 2.3.
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A Grass stimulator was connected to the Dagan 8100 
preamplifier so that current and voltage pulses could 
be delivered to the neurone under investigation. The 
recordings of current and voltage were monitored on a 
three channel Tektronix 5113 oscilloscope and stored on 
Ampex four channel magnetic tapes using a Racal 405 
tape recorder. Permanent visual records were produced 
by a high quality Gould 220 brush chart recorder.
2.3.3 VOLTAGE CLAMPING
Since recordings requiring high frequency 
responses were not under investigation in this study, 
it was possible to voltage clamp the neurones with a 
single electrode rather than a two electrode system. 
This reduced the complexity of the experiments 
performed because on certain occasions recording, 
iontophoresis and pressure injection electrodes were 
used at the same time.
When voltage clamping with the single electrode, 
the Dagan 8100 preamplifier was at the switched 
clamp/voltage setting. When at this setting the system 
switches at high frequency from a sensing voltage mode 
to a current passing mode. The switching frequency in 
these experiments was set at 3KHz and the duty cycle 
was 50%. A 50% duty cycle meant that half the time was 
spent in each mode.
To eliminate high frequency oscillations occuring 
during high gain voltage clamping, the current record 
was filtered before being displayed on the chart
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recorder. A low pass filter made up from a lOOnF
'Icapacitor and a 160kfï resistor was used which gave a §
filter frequency of 9.9Hz.
2.3.4 IONTOPHORESIS
FMRPamide was applied to neuronal cell bodies by 
the process of iontophoresis. At neutral pH FMRFamide 
has a net positive charge. By applying a small positive 
current through a glass electrode containing a 5mM 
FMRFamide solution, it was possible to deliver a 
controlled amount of neuropeptide to the neurones. A 
common problem with iontophoresis was blockage of the 
electrode tips. This was overcome by adapting the 
preparation of the FMRFamide solution and fabrication 
of the electrodes.
Solid FMRFamide (Peninsula Laboratories) was 
dissolved in double distilled water. The volume was 
split equally between two centrifuge filter units 
(0.22/nm spin x filter units, Costar U.S.A). The Isolutions were spun in a microfuge (Heraeus Christ) at |
13000 r.p.m. for 30 seconds. Small aliquots of the 
filtered solutions were sucked into 1 ml syringes which 
had short lengths of narrow plastic tubing attached.
Electrodes were back-filled with neuropeptide from 
these syringes.
The electrodes were fabricated from the same glass 
type and pulled on the same puller as the recording 
electrodes. However, the glass capillary tubes were cut 
to shortened lengths to make the bodies of the
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electrodes shorter. The heating element of the puller 
was set at a lower value on the second pull which 
produced wider tipped electrodes. These had resistance |
values of 0.5 to 0.7MÜ when filled with 200mM KCl and 
were less susceptible to blockages than higher 
resistance electrodes. Although there was a danger that 
these iontophoresis electrodes may have been prone to 
leakage, this was overcome since they had short bodies 
and only needed to be filled with a small volume of 
solution. This resulted in there being a reduced head 
of pressure on the electrode tips.
Filled electrodes were mounted on a hydraulically 
operated Narashige micromanipulator. A Ag/AgCl wire 
through which current could be delivered, was inserted 
into the FMRFamide solution. This was connected to an 
iontophoresis programmer which had its own direct 
current battery power supply. Another Ag/AgCl wire 
connected to the programmer acted as the grounding wire 
and was placed in the saline within the bath. Using 
this programmer in conjunction with an electronic 
stimulator, it was possible to set the levels of 
ejection current, retain current, ejection current 
pulse duration and the duration between the pulses. The 
ejection current was usually set no higher than lOOnA 
with pulse durations between 1.5 and 2.5 seconds. A 
retain current of 10 to 20nA was generally used. The 
retain current was required to prevent any leakage of 
FMRFamide from the electrode tip. It had the opposite A
polarity (negative) to the ejection current and was
i
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applied constantly apart from when FMRFamide was 
ejected.
2.3.5 PRESSURE INJECTION
Due to the membrane insolubility of certain 
compounds used in some experiments on the Cl neurone, 
it was necessary to inject them directly into the cell 
body. This was achieved by applying controlled pulses 
of compressed air to a solution contained within an 
electrode using a Picospritzer unit (General Valve 
U.S.A.).
The electrodes used for pressure injection were 
identical to the iontophoresis electrodes. All of the 
solutions used in these electrodes were passed through 
0,22/um (Millipore) filters in order to prevent 
blockages in the tips. Fast green dye at a 
concentration of 1 % (w/v) was also included in the 
solutions so that successful injections could be 
visually verified.
A Ag/AgCl wire connected to a probe for a Neurolog 
preamplifier was incorporated into the airtight holder 
for pressure electrodes. This was used to provide a 
definite monitor of pressure electrode impalement of a 
neurone. The voltage signal from this preamplifier was 
displayed on the third channel of the Tektronix 5113 
oscilloscope.
î
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2.3.6 DILUTION FACTOR CALCULATION
Injection of a solution into the cell body of a 
neurone caused it to be diluted in the cytoplasmic 
fluid volume. The magnitude of this dilution depended 
upon the volume of solution injected from the electrode 
and the volume of the cell body.
The volume of solution injected from a pressure 
electrode was quantified as follows. A pressure 
electrode filled with 1 % (w/v) fast green dye solution 
made up in distilled water was placed in the electrode 
holder and manoeuvered into the Perspex bath which 
contained microscope immersion oil (Zeiss). An ejection 
was then carried out at a pressure pulse of 138kPa for 
10ms. These values for air pressure and pulse duration 
were typical for those used in experimental situations. 
The dyed distilled water formed a sphere in the 
immersion oil, the diameter of which could be measured 
using a microscope eyepiece micrometer. This value was 
used to calculate the volume (v) of the sphere and 
hence the volume of solution ejected using the formula 
V = 4/37T(radius)^. This procedure was carried out on 
ten occasions with the average volume ejected being 
lxlO" 1 2  litres (Ipl).
The volume of the Cl neurone cell body was 
estimated again by measuring its diameter and basing 
the calculation on the volume of a sphere. The neuronal 
cell body was not in a perfect spherical form. However, 
when the volume of the Cl neurone cell body isolated in 
culture situations was measured, it did form a more
"1
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perfect spherical shape and the value was similar to 
that of the in situ neurone. The volume of the cell 
body was calculated at an average of 1 x1 0 "^ litres 
(inl). Therefore, the dilution factor of a solution 
injected into the cell body of the Cl neurone was 
approximately 1 0 0 0  fold.
2.3.7 ARRANGEMENT OF EQUIPMENT
The Perspex bath from which recordings were made, 
perfusion system, light source, micromanipulators, 
preamplifier probes and the dissecting microscope were 
all arranged on a baseplate within a copper Faraday 
cage (simplified diagram shown in Figure 2.4). All 
pieces of equipment which could have acted as aerials 
for electrical noise were connected to a common ground 
along with the baseplate and Faraday cage. The ground 
used was that of the Grass stimulator. The electronic 
apparatus was arranged on a rack mounting next to the 
cage.
2.3.8 ELECTRQPHYSIOLOGICAL PREPARATION OF A NEURONE 
PRIOR TO EXPERIMENTATION
The steps outlined below describe the preparation |
necessary for an experiment where pressure injection of j
a solution was required. However, in all other 
experiments where voltage clamping and neuropeptide 
application were used, the same proceedure was carried 
out, minus the pressure electrode.
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With the cell body having been exposed, the tip of 
the recording electrode was placed in the bath saline 
using a Narashige micromanipulator. In current clamp 
mode the resistance of the electrode was checked. It 
was then moved close to the cell body. When the 
electrode actually touched the cell membrane this 
registered as a slight hyperpolarization on the voltage 
trace observed on the oscilloscope. The neurone was 
carefully impaled using the fine controls of the 
micromanipulator. The immediate level of 
hyperpolarization was a measure of the resting membrane 
potential of the neurone. The neurone was then actively 
hyperpolarized by injecting negative current from the 
Dagan through the electrode. This helped the neurone to 
recover from the original trauma of impalement. The 
perfusion of saline was then started which also aided 
neurone recovery.
An iontophoretic electrode containing FMRFamide 
solution was placed into the bath using a hydraulically 
operated Narashige micromanipulator. Once in the bath 
saline, the iontophoresis programmer was switched on 
and a retain current applied to the FMRFamide solution. 
An ejection current was applied to check if the 
electrode was free from any possible blockage. The 
electrode was then moved close (lO-lOO/nm) to the cell 
body.
A pressure injection electrode mounted on an air 
tight holder was manoeuvered into the bath saline using 
a third Narashige micromanipulator. An air pressure 
test pulse was passed through the electrode checking
1
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for uninhibited flow of dyed solution from the tip. The 
Neurolog preamplifier was switched on and the voltage 
signal from this monitored on the oscilloscope. The 
neurone was impaled by careful operation of the fine 
controls of the manipulator. Impalement of the neurone 
resulted in this voltage signal moving in the 
hyperpolarizing direction. However, the overall effect 
of pressure electrode impalement was a depolarization 
of the neurone resulting in spiking. More 
hyperpolarizing current was delivered through the 
recording electrode from the Dagan to aid the recovery 
of the neurone from this second impalement. The 
pressure electrode was withdrawn very slightly from its 
original position within the cell body. This ensured 
that the electrode tip was not compressed against the 
nucleus or opposite side of the cell body, hence 
avoiding blockage.
With all three electrodes in position the Dagan 
was switched to voltage clamp mode and the experiment 
could begin.
2.4 PATCH CLAMP METHODS
2.4.1 PATCH PIPETTES
The fabrication process for patch pipettes 
consisted of a number of steps which have been 
described by Hamill et al (1981) with a few 
modifications.
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Patch pipettes were made from thin walled 
borosilicate glass capillary tubes (Clark 
Electromedical Instruments, type GC150T-15). Prior to 
pulling pipettes, the ends of the glass capillary tubes 
were rounded in a Bunsen burner flame and pipettes were 
pulled on the Narashige PP-83 two stage puller. To 
check that the pipette tip sizes were fairly constant 
the qualitative bubble test was used (Corey 
and Stevens, 1983). This test involved connecting the 
pipette to a 1 0 ml syringe through airtight polythene 
tubing. With the plunger set on IQmls of air, the 
pipette tip was placed in a small bottle filled with 
70% (v/v) ethanol. Pressure was applied to the plunger 
until there was the first sign of bubbles emerging from 
the tip. The reading on the syringe was taken. A value 
of 6 mls was required for the patch pipettes.
The pipettes were then placed on the bubble test 
syringe again and the tips were dipped into a 
dimethyldichlorosilane solution (BDH) under positive 
pressure. The positive pressure prevented blockage of 
the tips. Coating them in this solution treated the 
glass in such a way as to make it non-conducting and 
therefore the noise characteristics were reduced. The 
coating was allowed to dry at room temperature for at 
least 1 hour with the pipettes placed in Petri dishes 
as a protection from dust.
It was necessary to polish the pipette tips since 
Gigaohm seals can usually only be obtained with smooth 
pipette tips. This was achieved by melting the tips 
slightly. To carry this out the pipette was mounted on |
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a microscope slide and viewed under phase contrast at 
X250 magnification. The polishing heat was provided by 
a U-shaped platinum-iridium wire connected to a 6 volt 
(V) variable output power supply. It was important to 
have a glass bead melted onto the tip of the wire to 
prevent metal deposits evaporating onto the pipette tip 
during the polishing process. The polishing wire was 
attached to a micromanipulator held on an adjustable 
clamp to allow it to be positioned and viewed under the 
microscope. An air jet supplied by a small electrical 
pump was directed at the tip of the wire to reduce 
fluctuations in temperature due to drafts of air in the 
room. Focussing on both the pipette tip and wire under 
the microscope, the wire was heated causing it to 
expand. The pipette tip was positioned close to the 
wire until a slight distortion of the tip was observed 
which indicated that melting had occured.
The pipettes were again subjected to the bubble 
test where a value of 4 to 5mls was required. They were 
stored in Petri dishes and used within two days of 
their fabrication.
2.4.2 FILLING PIPETTES
To prevent tip blockages, solutions were passed 
through a 0.22pm (Millipore) filter prior to use. The 
pipettes were filled in two stages. With a pipette held 
in a bubble test syringe, the tip was positioned in a 
small bottle of filtered solution. Negative pressure 
was applied until the tip could be seen to fill with
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solution. The pipette was then back-filled using a 
syringe and hypodermic needle with a Millipore filter 
mounting attached. Any bubbles were removed by lightly 
tapping the pipette.
2.4.3 RECORDING APPARATUS
The patch clamp recordings were made using a List 
EPC5 patch clamp preamplifier. Unitary currents and 
patch potentials were monitored on a two channel 
Nicolet oscilloscope. A voltage pulse was supplied to 
the patch amplifier from a Grass stimulator so that 
Gigaohm seal formation could be monitored by measuring 
pipette tip resistance. All data was recorded on video 
tape using a video cassette recorder (JVC). The data 
was converted from analogue to digital signals for 
video recording by a pulse code modulator (Sony). The 
filtering on the patch clamp amplifier was set at 3kHz, 
The recordings were passed through a Neurolog 
adjustable low pass filter unit which was usually set 
at IkHz before monitoring on the oscilloscope. 
Permanent visual records were obtained by playing the 
data through a high quality Gould 220 brush chart 
recorder. The Perspex bath containing the experimental 
preparation was grounded by an Ag/AgCl wire connected 
to the ground input of the patch clamp preamplifier 
headstage.
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2.4.4 ARRANGEMENT OF EQUIPMENT
The Perspex bath containing the preparation was 
exactly the same as that used for intracellular 
recording. The perfusion system was also essentially 
the same except that there was only one inflow line 
from a single reservoir which contained normal Helix 
saline. No multiwell tap was required.
The equipment was arranged on a baseplate within a 
copper Faraday cage, essentially in a similar manner as 
was described for intracellular recordings. Again all 
pieces of equipment which had the potential to act as 
aerials for electrical noise were connected to a common 
ground along with the baseplate and Faraday cage. The 
high quality signal ground of the patch clamp 
preamplifier was used. When experiments were being 
performed, any remaining noise was reduced by bringing 
down the front of the Faraday cage.
The baseplate was mounted on an anti-vibration air 
table (Wentworth Laboratories) and air was provided 
from a high pressure cylinder. A diagram showing the 
arrangement of equipment is given in Figure 2.5.
2.4.5 FORMATION OF CELL ATTACHED PATCHES AND FMRFamide 
APPLICATION
Patch pipettes filled with solution were mounted 
on the Ag/AgCl wire of the preamplifier headstage and 
held in an airtight pipette holder. Positive or 
negative pressure could be applied to this holder
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through a length of plastic tubing attached to a 2 ml 
syringe. Positive pressure was applied prior to placing 
the pipette in the bath solution to prevent any 
possible debris blocking the tip. Once the pipette tip 
had been manoeuvered into the bath saline using a 
Narashige micromanipulator, the preamplifier was 
switched on in "search" mode and the direct current 
offset set to zero. A voltage pulse was passed through 
the preamplifier to the patch pipette so that tip 
resistances could be monitored by measuring the 
resulting current pulses. Pipette tip resistances were 
typically 2Mf2 with normal Helix saline in the pipette. 4
The pipette tip was carefully moved down towards 
the cell body of the neurone. When the cell body was 
touched, the current pulse reduced slightly and the 
noise level on the current recording was reduced.
Gentle suction was then applied from the syringe. If 
the current pulse reduced to zero with a further noise 
reduction then this indicated that a high resistance 
Gigaohm seal had been obtained. On a number of 
occasions the pipette would rupture the cell membrane, 
hence moving into a whole cell recording situation. If 
the patch clamp amplifier was switched to current clamp 
mode, the resting membrane potential could be measured 
and the hyperpolarizing effect of FMRFamide monitored.
When a cell attached patch had been formed the 
preamplifier was switched to voltage clamp mode and the 
pipette potential set as required.
The aim of the experiments on cell attached 
patches was to apply FMRFamide to the external surface
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of the neuronal cell body outwith the patch. FMRFaiaide 
was applied by passing controlled pulses of compressed 
air to a solution contained within an electrode using a 
Picospritzer unit. The electrodes used were exactly the 
same as those described for pressure injection during 
intracellular recording. The ends of FMRFamide 
containing electrodes were attached to the Picospritzer 
unit using tight fitting, air tight polythene tubing. I
They were manoeuvered into position close to the cell ^
body by a hydraulically operated Narashige 
micromanipulator. Only small pressures and pulse 
durations were required to deliver sufficient volumes 
of FMRFamide solution (typically 69kPa, 30ms duration).
2.5 SOLUTIONS
2.5.1 HELIX SALINE
Three salines were used. One was termed "normal 
saline" and the others "ONa’*'" and "OCa^"^". Constituent 
listings of each are given below;
Normal saline: 80mM NaCl, 5mM KOI, 5mM MgCl2 ,
7mM CaCl2 , 20mM Hepes, pH 7.5 with NaOH.
ONa+ saline: 160mM sucrose, 5mM KOI, 5mM MgCl2 ,
7mM CaCl2 / 20mM Hepes, pH 7.5 with KOH.
OCa^t saline: 80mM NaCl, 5mM KCl, 9.5mM MgCl2 ,
2mM EGTA, 20mM Hepes, pH 7.5 with NaOH.
;   -'i - . 'X:: 1
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EGTA and Hepes buffer (free acid) were obtained 
from Sigma, All other salts were obtained from BDH.
2.5.2 NEUROPEPTIDE SOLUTIONS
A description for the preparation of the 5mM 
FMRFamide solution used for iontophoresis has been 
described in the iontophoresis section of intracellular 
recording (2.3.4).
For pressure ejection during patch clamping 
experiments, FMRFamide was dissolved in normal saline 
at a concentration of 1 0 0 juM and filtered through a 
0.22/xm Millipore filter. FMRFamide was obtained from 
Peninsula Laboratories.
2.5.3 MEMBRANE SOLUBLE SECOND MESSENGER ANALOGUES, 
ENZYME ACTIVATORS AND INHIBITORS
8-(-4) CPT cyclic AMP (Boehringer Mannheim), 
dibutyryl cyclic AMP (Sigma), dibutyryl cyclic GMP 
(Sigma), 8 -bromo cyclic GMP (Sigma) and IBMX (Sigma) 
were dissolved directly in normal Helix saline and used 
at concentrations of 100/iM and ImM.
Concentrated stock solutions of phorbol 12,13- 
dibutyrate (Sigma) and arachidonic acid (Sigma) were 
initially dissolved in 100% DMSO (Sigma) at 
concentrations of lOOmM. Aliquots were diluted down to 
50/iM phorbol 12,13-dibutyrate (0.05% (v/v) DMSO) and 
50pM arachidonic acid (0.05% (v/v) DMSO) in normal 
saline. Okadaic acid was received (Prof. P. Cohen,
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University of Dundee) at a concentration of lOmM in 
100% DMSO. Aliquots were diluted down to 1/nM in normal 
saline (0.01% (v/v) DMSO).
2.5.4 DRUGS TO CHARACTERIZE THE FAST Na+ RESPONSE
C0 CI2 (BDH), tetrodotoxin (Sigma) and amiloride 
(Sigma) were all dissolved in normal saline at 
concentrations of ImM, 50/iM, and 100/iM respectively. 
Lignocaine (Sigma) was firstly dissolved in lOOmM HCl 
to make the lignocaine hydrochloride salt. This was 
then diluted in normal saline and the pH was adjusted 
to 7.5 with NaOH. The final concentration of lignocaine 
was ImM.
2.5.5 INTRACELLULARLY INJECTED COMPOUNDS
a) GTP*S (Sigma), EGTA and inositol 
1,4,5-trisphosphate (IP3).
GTPfS (Sigma), EGTA (Sigma) and IP3 (Amersham) 
were diluted to concentrations of lOmM, 700mM and 
0.78mM respectively in a solution which consisted of 
lOOmM KCl, 20mM Hepes, 1% (w/v) fast green dye, pH 7.4 
with KOH. The solvent was passed through a 0.22pm 
Millipore filter.
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b) Pertussis toxin.
Two solutions were required to activate pertussis 
toxin. The constituents of the solutions are listed 
below.
Solution 1 : lOmM DTT (Sigma), 25mM MOPS buffer,
200mM KCl, pH 7.5 with KOH.
The solution was made up in distilled water.
Solution 2 : lOmM NAD (Sigma), lOmM ATP (Sigma) made
up in an aliquot of solution 1 .
1 % (w/v) fast green dye was added to solution 2 . 
The solution was then passed through a 0.22pm Millipore 
filter. Pertussis toxin (Sigma) was dissolved in 
Solution 2 to the required concentration of 0.5mg/ml 
and the temperature of the reaction mixture was raised 
to 35°C for 15 minutes in a water bath. This allowed 
DTT to reduce disulphide bonds and activate the toxin.
Chapter 3 
Results
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3.1 THE SLOW HYPERPOLARIZING FMRFamide RESPONSE OF |
THE Cl NEURONE
FMRFamide application to this neurone resulted in 
a slow hyperpolarization at a resting membrane 
potential which averaged -50mV (40 neurones). The 
hyperpolarization was associated with a decrease in 
input resistance as indicated by the reduction in size 
of the voltage deflections elicited by constant 
hyperpolarizing current pulses. Although the current 
clamp record in Figure 3.la shows the Cl neurone 
spiking at the resting membrane potential, this did not 
normally occur. The spikes appeared here as a rebound 
artifact caused by the delivery of hyperpolarizing 
current pulses.
When the Cl neurone was voltage clamped at -45mV, 
the membrane current underlying the hyperpolarization 
was clearly seen. The current was slow and outward in 
direction. The average time taken between FMRFamide 
application and the maximum amplitude of the response 
was approximately 7 seconds. The decrease in input 
resistance caused by FMRFamide was observed as an 
increase in amplitude of the current pulses which were 
elicited by a constant hyperpolarizing voltage step.
The relation between the current response and the 
holding membrane potential is shown in Figure 3.2. The 
reversal potential for the response was approximately 
-70mV. The overall relationship was not linear. The 
nature of the relationship was characteristic of the 
constant field equation which describes the movement of
a) Vm -48mV
W yTfinnnfiTil^ ^
20mV
10s
b) Vh -45mV
rrrrrrr ^nrrrrrn
O.SnA
10s
Figure 3.1 a) and b)
Recordings of the slow, outward current induced by 
FMRFamide in two different Cl neurones, one under 
current clamp and the other under voltage clamp 
conditions, a) Current clamp recording from a neurone 
which had a resting membrane potential (Vm) of -48mV. 
Voltage deflections resulting from constant 
hyperpolarizing current pulses were used to monitor 
input resistance, b) Voltage clamp recording from 
another neurone at a holding potential (Vh) of 
“45mV. Current deflections induced by a constant 
hyperpolarizing voltage step were used to monitor input 
resistance. FMRFamide was applied in both records at 
the points marked by the black dots.
4
Q.
-80
-20-60 -40
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-100
Figure 3 . 2
The relationship between amplitude of the 
FMRFamide response and holding potential. The reversal 
potential was -70mV.
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an individual ionic species moving across the membrane 
by simple diffusion along a potential gradient. The 
value of the reversal potential indicated that the 
outward current response to FMRFamide may have been due 
to the movement of K"^ . Previous experiments with ion 
substitution and ion channel blockers showed that the 
outward current was indeed carried by (Cottrell, 
1982; Cottrell et al. 1984).
Cottrell (1982) also showed that when the neurone 
was depolarized from resting membrane potential, the 
response became biphasic with an inward, as well as an 
outward current component. Further depolarization 
changed the response to an inward current only. The 
inward current was subsequently studied and found to be 
the result of the closure of K"*" channels (Cottrell et 
al. 1984). This voltage dependent inward current is 
similar to that induced by 5-HT in the Cl neurone at 
depolarized potentials (Cottrell, 1982).
3.2 ANALYSIS OF THE INTRACELLULAR MECHANISM WHICH
UNDERLIES THE FMRFamide INDUCED K+CURRENT IN THE
Cl NEURONE
The slow nature of the FMRFamide response suggests 
that the receptor may be linked to the ion channel 
through the activation of a guanine nucleotide binding 
protein (G protein) and possibily through a second 
messenger pathway. Many, but not all of the actions of 
these second messenger cascades are mediated by protein 
phosphorylation. A number of second messenger cascades
■' * ' \ i. '-.-.r -S.-- > .:-r- ■
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have now been characterized, examples of which involve 
cyclic AMP and cyclic GMP-mediated protein 
phosphorylation, the breakdown products of 
phosphatidylinositol 4,5 bisphosphate (IP3 and 
diacylglycerol), arachidonic acid and its metabolites 
and finally, intracellular Ca^^, All of the above are 
candidates for the mechanism which underlies the 
FMRFamide response under investigation. Each has been 
tested and is referred to in the following sections.
3.3 INVOLVEMENT OF A G PROTEIN
G proteins have been identified in almost all 
cells in every tissue and their major role is known to 
be the transduction of various extracellular signals by 
interacting between receptor molecules and effector 
enzymes or ion channels. Several different molecular 
probes that regulate G protein activity are now 
available to study the modulation of ion channels. The 
substances used in the following experiments were GTPfS 
and pertussis toxin (islet activating protein).
3.3.1 GTPfS INJECTION EXPERIMENTS
GTPfs is a non-hydrolysable analogue of GTP which 
has been used to cause persistent activation of G 
proteins (Rodbell,1980). GTPfS is not specific for the 
activation of any one type of G protein. For example, 
it can activate G proteins which stimulate adenylate
7 1
cyclase (Gg), G proteins which inhibit adenylate 
cyclase (G^) and other G proteins (Gq ).
GTPfS was dissolved in a solvent solution 
consisting of lOOmM KCl, 20mM Hepes buffer, 1% (w/v) 
fast green, pH 7.4 with KOH (Brezina, 1988). Injection 
of the solvent alone (3 replicate experiments) had no 
long-term effect on the amplitude of the FMRFamide 
response but it did induce a very slight inward current 
(Figure 3.3). However, the inward current was small and 
did not effect the experiments with GTP*S. Figure 3.4 
shows the record of an experiment where GTPfS was 
injected at a concentration of lOmM. Taking the 
intracellular fluid volume and volume of GTPfS injected 
into account (see Methods), the estimated final 
intracellular concentration of GTP*S was 10-100/iM. This 
concentration range was similar to that used by Sasaki 
and coworkers, (1987a and b) when injecting GTP*S into 
Aplysia neurones. GTPfS induced an outward current 
which was associated with an increase in membrane 
conductance, as indicated by the increase in size of 
the current deflections. Also, the outward current 
responses to FMRFamide were depressed following the 
development of the outward GTP*S current. The final 
level of the baseline membrane current was 
approximately equal to that of the peak outward current 
of the control responses to the neuropeptide.
If the record in Figure 3.4 is examined closely, 
it appears that the baseline membrane current was 
already moving slightly outward with the GTPis 
electrode impaled into the neurone prior to injection. J
Figure 3.3
The effect of injection of the solvent used for 
the GTPfS experiments into the cell body of a Cl 
neurone. The neurone was voltage clamped at -45mV. The 
upper graph shows that solvent injection transiently 
increased the amplitude of the FMRFamide response. The 
response amplitude then returned close to control 
levels. The solvent injection also produced a very 
small inward current which persisted for the duration 
of the experiment (lower graph). The dashed line on the 
lower graph indicates the baseline current level at the 
time of injection (time zero). The point of injection 
is marked by the vertical arrow on each graph.
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In some neurones this outward current was larger and 
developed only 1 - 2  minutes after impaling the neurone. 
With these neurones it was difficult to elicite any 
FMRFamide responses. These events indicated that GTPfS 
was leaking into the neurones prior to injection.
These results strongly suggest the involvement of 
a G protein in the FMRFamide induced, outward 
current.
3.3.2 PERTUSSIS TOXIN EXPERIMENTS
The bacterial toxin, pertussis toxin, inhibits the 
actions of the G proteins Gj^  (inhibits adenylate 
cyclase) and Gq (some other function) in the presence 
of nicotinamide adenine dinucleotide (NAD) (Neer et al, 
1984) by ADP-ribosylation of the a subunits of these G 
proteins. Figure 3.5 shows a voltage clamp recording 
where pre-activated pertussis toxin was injected at a 
concentration of 0.5mg/ml to give an estimated 
intracellular concentration of 0.5-5pg/ml (see 
Methods). Pertussis toxin quite clearly reduced the 
amplitude of the FMRFamide response (to 42% of its 
original amplitude) over a period of approximately 1 2 0 0  
seconds (20 minutes). Injection of the activation 
solution (200mM KCl, lOmM DTT, lOmM NAD, 25mM MOPS, 1% 
(w/v) fast green, pH 7.4) had no effect on the 
amplitude of the FMRFamide responses. The results 
obtained with the activation solution (control) and 
pertussis toxin are compared graphically in Figure 3.6.
‘     '    < ■'___■_;_L .." j
Figure 3.5
The effect of pre-activated pertussis toxin 
injection into the cell body of a Cl neurone voltage 
clamped at -45mV. FMRFamide was applied at the points 
marked by the black dots and pertussis toxin (0.5mg/ml) 
was injected at the point indicated by the arrowhead. 
The amplitude of the FMRFamide responses gradually 
reduced over a period of approximately 1 2 0 0  seconds ( 2 0  
minutes) after injection. The time marked above each 
record refers to the first FMRFamide response in that 
record relative to pertussis toxin injection (time 
zero).
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Figure 3.6
The comparison of the effects of injecting 
activating solution (control) and activating solution 
containing pertussis toxin on the amplitude of the 
FMRFamide response of Cl neurones voltage clamped at 
-45mV. The FMRFamide responses were normalised. The 
point of injection for both experiments is shown by the 
vertical arrow. The activating solution had no effect 
but pertussis toxin reduced the amplitude of the 
responses.
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Similar effects to those described above were observed 
in three other Cl neurones.
3.4 CYCLIC NUCLEOTIDES
Of the several second messengers which have been 
characterized and shown to be the link between 
neurotransmitter receptors and ion channels, the two 
most studied have been the cyclic nucleotides, cyclic 
AMP and cyclic GMP.
Intracellular levels of the cyclic nucleotides can 
be increased experimentally either by direct injection 
or by exposing the neurones to membrane soluble 
analogues. The use of membrane soluble analogues is 
technically simpler. This method has been used in these 
studies. Usually very high concentrations (100#M-imM) 
of the membrane soluble analogues must be applied 
before any effects can be detected. There are two 
reasons for this. Firstly, neurones may not be very 
permeable to a particular cyclic nucleotide analogue 
and secondly, such analogues may be subject to rapid 
metabolism by phosphodiesterase enzymes. The levels of 
cyclic nucleotides in a cell are normally controlled by 
the synthetic and degradative processes. The inhibition 
of phosphodiesterase enzymes therefore, can also be 
used to elevate the levels of cyclic nucleotides in 
cells.
;'T.= _
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3.4.1 THE CYCLIC AMP SYSTEM
The two membrane soluble analogues of cyclic AMP 
used in these experiments were 8 -(-4) CTP cyclic AMP 
and dibutyryl cyclic AMP. The 8 -(-4) CPT cyclic AMP 
derivative has been reported to be a hundred times more 
effective than dibutyryl cyclic AMP in the activation 
of cyclic AMP dependent protein kinase A in rat liver 
and to be more resistant to phosphodiesterase activity 
(Miller et al, 1975).
The voltage clamp recordings in Figure 3.7 
illustrates the actions of ImM 8-(-4) CPT cyclic AMP 
when applied to a Cl neurone. This substance had two 
clear effects. Firstly, the amplitude of the FMRFamide 
response was rapidly reduced (within 60 seconds) 
leading to complete abolition of the response after 
approximately 300 seconds (5 minutes) (2 replicate 
experiments (n=2)). Secondly, an inward current was 
induced which reached a maximum amplitude in 360 
seconds (7 minutes) (n=2). This inward current was 
associated with an increase in size of the current 
pulses elicited by a constant voltage step, indicating 
that the membrane conductance had increased to some 
ion(s). Both effects were reversed on washing for 720 
seconds (12 minutes) with normal saline. No further 
investigations were made on the inward current. Data 
from the experiment are shown in Figure 3.8.
In another experiment imM 8-(~4) CPT cyclic AMP 
also reduced the FMRFamide response but only to 30% of 
its original amplitude and the inward current was also
Figure 3.7
The effect of litiM 8 -(-4) CPT cyclic AMP dissolved 
in the perfussing saline on the amplitude of the 
FMRFamide response and baseline current level for a Cl 
neurone voltage clamped at -45mV. Application of 8 -(-4) 
CPT cyclic AMP is indicated by the lines underneath the 
records. The time, relative to the start of application 
(time zero) is marked above each section of record. The 
arrows to the left of each record show the original 
level of the baseline current at time zero. Current 
deflections evoked by a constant hyperpolarizing 
voltage step were used to monitor input resistance.
Note the reversible inward current induced by 8-(-4)
CPT cyclic AMP, the decrease in input resistance and 
the reversible reduction of the amplitude of the 
FMRFamide response. FMRFamide was applied at the points 
marked by the black dots.
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Figure 3 . 8
The influence of ImM 8-(-4) CPT cyclic AMP on a Cl 
neurone which was voltage clamped at -45mV. The upper 
graph shows the reversible reduction of the amplitude 
of the FMRFamide response and the lower graph the 
reversible baseline inward current. The application of 
8-(-4) CPT cyclic AMP is marked by the bars on each 
graph. The original baseline current level at time zero 
is indicated by the dashed line on the lower graph.
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smaller. This was likely to have been due to a poorer 
penetration of the 8 -(-4) CPT cyclic AMP.
When dibutyryl cyclic AMP was applied to the Cl 
neurone it had absolutely no effect on either the 
FMRFamide response amplitude or the baseline membrane 
current (n=3), possibly because the dibutyryl 
derivative is more susceptable to phosphodiesterases 
and/or is less potent on the activation of cyclic AMP 
dependent protein kinase A (see above).
Cyclic AMP is relatively membrane insoluble and 
was used as a control to check whether 8 -(-4) CPT 
cyclic AMP could have a non-specific action on the 
external surface of the membrane. An example recording 
of such an experiment is shown in Figure 3.9. External 
application of ImM cyclic AMP for a period of up to 690 
seconds (11.5 minutes) had no effect on the baseline 
membrane current level or the amplitude of the 
FMRFamide response (n=2). The data obtained from the 
experiment are plotted in Figure 3.10. This result 
indicates that the effects of 8 -(-4) CPT cyclic AMP 
were unlikely to have been due to an external, non­
specific action.
To implicate a substance as a second messenger, 
application of the second messenger should in some way 
mimic the action of the ligand in question. Since 
8 -(-4) CPT cyclic AMP did not cause an outward current 
to develop or potentiate the FMRFamide response, cyclic 
AMP can be ruled out as the second messenger for the 
FMRFamide response.
Figure 3.9
This control experiment shows that extracellularly 
applied ImM cyclic AMP in the perfusing saline had no 
effect on the amplitude of the FMRFamide response or 
baseline current level of a Cl neurone voltage clamped 
at “45mV. Cyclic AMP application is marked by the lines 
underneath the records. The time indicated above each 
record refers to the first FMRFamide response in that 
record relative to the start of application (time 
zero). The arrows to the left of the records show what 
was the baseline current level at time zero. FMRFamide 
was pulsed onto the neurone at points marked by the 
black dots. The inward deflections on the records are 
undamped axon spikes.
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Figure 3.10
Data obtained from an experiment where ImM cyclic 
AMP was applied to a voltage clamped Cl neurone held at 
-45mV, showing the lack of effect on the amplitude of 
the FMRFamide response (upper graph) and baseline 
current level (lower graph). Cyclic AMP application is 
marked by the bars on each graph. The original level of 
the baseline current at time zero is shown by the 
dashed line on the lower graph.
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3.4.2 THE CYCLIC GMP SYSTEM
The membrane soluble analogues of cyclic GMP used 
in these experiments were 8 -bromo cyclic GMP and 
dibutyryl cyclic GMP. Exposure to ImM 8 -bromo cyclic 
GMP for 910 seconds (approximately 15 minutes) had no 
effect on the amplitude of the FMRFamide response but 
it did induce a relatively large inward current (2.0nA) 
over this time period (Figure 3.11). The inward current 
induced by 8 -bromo cyclic GMP had not reached a plateau 
value by the end of the experiment (n=3). This inward 
current was not investigated further.
With ImM dibutyryl cyclic GMP application there 
was no change in either the amplitude of the FMRFamide 
response or the baseline membrane current (n=2). This 
was similar to the situation with dibutyryl cyclic AMP.
These results suggest that cyclic GMP is not 
involved in the outward current evoked by FMRFamide in 
the Cl neurone.
3.4.3 PHOSPHODIESTERASE INHIBITION
Inhibition of the phosphodiesterase enzymes which 
metabolize cyclic AMP and cyclic GMP is another method 
whereby the intracellular concentrations of these 
cyclic nucleotides can be increased. The membrane 
soluble xanthine compound IBMX was the 
phosphodiesterase enzyme inhibitor used in this study.
Figure 3.12 shows the influence of ImM IBMX on the 
FMRFamide response and baseline current of a Cl neurone
Figure 3.11
Data from an experiment where ImM 8 -bromo cyclic 
GMP was applied to a Cl neurone voltage clamped at 
-45mV. It had no effect on the amplitude of the 
FMRFamide response (upper graph) but did induce an 
inward current which had not reached a plateau after 
930 seconds (15.5 minutes) (lower graph). 8 -bromo 
cyclic GMP application is shown by the bars on each 
graph. The baseline current level at time zero is 
marked by the dashed line on the lower graph.
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Figure 3.12
Data obtained when examining the influence of ImM 
IBMX application on the amplitude of the FMRFamide 
response and baseline current level of a Cl neurone 
voltage clamped at -45mV. IBMX reversibly reduced the 
amplitude of the FMRFamide response (upper graph) and 
induced a reversible inward current (lower graph). 
Application of IBMX is indicated by the bars on each 
graph. The original baseline current level at time zero 
is shown by the dashed line on the lower graph.
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which was voltage clamped at -45mV. The reduction in 
response amplitude reached a maximum (approximately 35% 
of the original response) in 1 2 0  seconds ( 2 minutes). 
The response was completely reversed after 480 seconds 
( 8  minutes) of washing with normal saline (n=3). IBMX 
also induced an inward current (Figure 3.12 lower 
graph) which reached a maximum amplitude in 1 2 0  seconds 
(2 minutes). This effect was reversed after 420 seconds 
(7 minutes) of washing (n-3). These results parallel 
those seen when 8-(-4) CPT cyclic AMP was applied to 
the Cl neurone.
3.5 A ROLE FOR 5-HYDROXYTRYPTAMINE (5-HT)
The reduced amplitude of the FMRFamide response 
obtained in the presence of elevated cyclic AMP levels 
closely resembled observations made by Brezina and co­
workers, (1987a) with Aplysia neurones. They discovered 
that 5-HT could mimic the effect of cyclic AMP and 
therefore suggested that the suppression of the 
FMRFamide induced outward current by 5-HT was mediated 
by an increase in intracellular cyclic AMP levels.
Figure 3.13 shows the effect of lOOpM 5-HT on 
FMRFamide responses in a Cl neurone. 5-HT reduced the 
FMRFamide response to between 20 and 40% of its 
original amplitude within 30 seconds of application. 
5-HT also induced a small inward current (0.2nA). A 
full recovery of the FMRFamide response and the inward 
current occurred with washing the preparation with
J, f - '____._ '.'K V - ■■_;__ ii.." c’-!-': -jV'' I: 0,. . i‘v.
Figure 3.13
The effect of 100/iM 5-HT application on the 
amplitude of the FMRFamide response and baseline 
current level on a Cl neurone, voltage clamped at 
-45mV. 5-HT reversibly reduced the amplitude of the 
FMRFamide response and induced an inward current. The 
reduction in the amplitude of the FMRFamide response 
reduced in the continued presence of 5-HT. 5-HT 
application is shown by the lines beneath the records. 
The time marked above each record refers to the first 
FMRFamide response in that record relative to the start 
of 5-HT application which was time zero. The baseline 
current level at time zero is shown by the arrows to 
the left of the records. Pulses of FMRFamide were 
administered to the neurone at points indicated by the 
black dots. The inward deflections on the records are 
undamped axon spikes.
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normal saline (n=6 ). The data are plotted in Figure 
3.14.
5-HT was also applied to the Cl neurone in the 
presence of ImM IBMX so that levels of cyclic AMP were 
elevated. The data obtained are plotted in Figure 3.15. 
The data generated with 5-HT alone are also plotted in 
Figure 3.15 for comparison. Two obvious differences in 
these data can be seen as regards both the FMRFamide 
response and the 5-HT induced inward current (n=2). 
Firstly, the reduction of the FMRFamide,response was 
greater with the inclusion of IBMX, reaching to only 7% 
of the original response amplitude remaining. The 5-HT 
induced inward current was much larger, reaching a 
maximum amplitude of 1.2nA. Secondly, upon washing with 
normal saline the recovery times were longer. In fact 
the FMRFamide response did not fully recover for the 
duration of the experiment.
These results indicated that 5-HT may be a 
transmitter substance that normally induces elevation 
of cyclic AMP, which in turn causes a reduction in 
amplitude of the FMRFamide response. Also, the 5-HT 
induced inward current is probably mediated by an 
increase in cyclic AMP levels.
3 . 6  INOSITOL 1.4.5-TRISPHOSPHATE flPy^ AND PROTEIN
KINASE C
Receptor-mediated hydrolysis of 
phosphatidylinositol 4,5 bisphosphate (PIP2 ) by 
phospholipase C, is another mechanism for information
Figure 3.14
Data from the experiment where IOO/2M 5-HT was 
applied to a Cl neurone voltage clamped at -45mV. 5-HT 
reversibly reduced the amplitude of the FMRFamide 
response (upper graph) and produced a small, reversible 
inward current (lower graph). The reduction in the 
amplitude of the FMRFamide response reduced in the 
continued presence of 5-HT. 5-HT application is 
indicated by the bar in each graph. The baseline 
current level is indicated by the dashed line on the 
lower graph.
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Figure 3.15
A comparison of the effects of 100/iM 5-HT alone 
and 100/iM 5-HT plus ImM IBMX on the amplitude of the 
FMRFamide response and baseline current levels for Cl 
neurones voltage clamped at -45mV. In the presence of 
IBMX, 5-HT reduced the amplitude of the FMRFamide 
response to a greater extent and this effect was 
prolonged in comparison to 5-HT only (upper graph). The 
FMRFamide responses were normalised to make the 
comparison. The presence of IBMX also potentiated and 
prolonged the inward current (lower graph).
Applications of 5-HT and 5-HT with IBMX are indicated 
by the bars in each graph. Cell 1 refers to the 
experiment where 5-HT alone was used while cell 2 was 
the experiment where 5-HT was applied with IBMX. The 
baseline current level at time zero is indicated by the 
dashed line in the lower graph.
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transduction from various extracellular signals into 
neurones. The immediate products in this catalytic 
action, inositol 1 ,4,5-trisphosphate (IP3 ) and 1 ,2 - 
diacylglycerol (DAG) act as second messenger molecules 
at the beginning of a two way transduction pathway 
involving the mobilization of Ca^^ from intracellular 
storage pools and activation of the protein kinase C 
enzyme family.
3.6.1 INOSITOL 1.4.5-TRISPHOSPHATE
Figure 3.16 graphically illustrates the result of 
an experiment where IP3 , at concentration of 0.78mM, 
was pressure injected into a Cl neurone. The estimated 
intracellular concentration of IP3 was 0.78 - 7.8/iM 
(see Methods). No significant change in the baseline 
current level was observed up to 600 seconds ( 1 0  
minutes) after injection (n=3). Since there was no 
mimic of the FMRFamide response, it suggested that IP3 
was not the second messenger underlying the FMRFamide 
response.
3.6.2 PROTEIN KINASE C
Physiological activation of protein kinase C by 
DAG can be mimicked by certain tumour promoting phorbol 
esters. These sustances are active when applied 
extracellularly, a property which has made them 
extremely useful tools when studying the involvement of 1
-1
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Figure 3.16
The lack of effect on baseline current level 
following the injection of 0.78mM inositol 1,4,5- 
trisphosphate (IP3 ) into the cell body of a voltage 
clamped Cl neurone (Vj^  -45mV) . The injection point 
(time zero) is marked by the vertical arrow and the 
original baseline current level at time zero is 
indicated by the dashed line.
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protein kinase C in the opening and closure of ion 
channels.
Due to their hydrophobicity, phorbol esters must 
first be dissolved in an organic solvent such as 
dimethylsulfoxide (DMSO). In these experiments, where 
phorbol 12,13-dibutyrate was applied to the Cl neurone, 
the final concentration of DMSO in the perfusing 
solution was 0.05% (v/v). The experimental record shown 
in Figure 3.17 indicates that when controls with 0.05% 
(v/v) DMSO were performed (n==3), there were no changes 
in the amplitude of the FMRFamide response or the 
baseline current level over a period of 945 seconds 
(15.75 minutes).
The result obtained with the application of 50juM 
phorbol 12,13-dibutyrate (n=3) is illustrated in Figure 
3.18. Within 45 seconds of application, the amplitude 
of the FMRFamide response was reduced and an inward 
current developed. After 320 seconds (5,33 minutes) 
both effects appeared to have maximized. The 
preparation was then washed with normal saline. After 
washing for 240 seconds (4 minutes) the inward current 
had almost reduced to the original baseline current 
level, although the reduction in the FMRFamide response 
persisted. A longer washing period may have resulted in 
some recovery of the response. However, the neurones 
did not survive long enough to make this possible.
These results suggest that protein kinase C 
activation is not the mechanism which underlies the 
generation of the FMRFamide response in the Cl neurone.
à #
Figure 3.17
The administration of 0.05% (v/v) DMSO dissolved 
in normal saline had no effect on the amplitude of the 
FMRFamide response or baseline current level of a Cl 
neurone, voltage clamped at -45mV. DMSO application is 
marked by the lines underneath the records. The time 
shown above each record refers to the first FMRFamide 
response in that record relative to the start of DMSO 
application (time zero). The arrows to the left of the 
records show the original position of the baseline 
current level at time zero. FMRFamide was applied at 
the points marked by the black dots.
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Figure 3.18
The influence of phorbol 12,13-dibutyrate on the 
amplitude of the FMRFamide response and baseline 
current level on a Cl neurone voltage clamped at -45mV. 
This substance at a concentration of 50/LtM dissolved in 
0.05% (v/v) DMSO in normal saline produced an 
irreversible reduction of the amplitude of the 
FMRFamide response and an almost fully reversible 
inward current. The lines underneath the records mark 
where phorbol 12,13-dibutyrate was applied. The time 
marked above each record refers to the first FMRFamide 
response in that record relative to the start of 
application of phorbol 12,13-dibutyrate (time zero).
The arrows to the left of the records show the original 
level of baseline current at time zero. FMRFamide was 
applied at the points marked by the black dots. The 
rapid inward deflections in the upper record were 
undamped axon spikes.
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50|iM phorbol 12,13- dibutyrate
320s
50pM phorbol 12,13- dibutyrate
680s
Vh -45mV
O.SnA
10s
81
but protein kinase C could be important as a modulator 
of the FMRFamide response.
3.7 ARACHIDONIC ACID
Arachidonic acid is a polyunsaturated fatty acid 
which can be released from the esterified stores of 
membrane phospholipids by the action of Ca^^ requiring 
phospholipases. Arachidonic acid can then be 
metabolized to a number of biologically active 
oxidation products which are known as eicosanoids. One 
of the main breakdown pathways for arachidonic acid 
involves the lipoxygenase enzymes which produce 
leukotrienes, hydroxyeicosatetraenoic acids (HETE), 
hydroperoxyeicosatetraenoic acids (HPETE) and lipoxins. 
Piomelli et al. (1987) have provided evidence that the 
receptor-stimulated release of arachidonic acid and its 
metabolism through to 12-HPETE or subsequent products, 
mediates the inhibitory synaptic response of FMRFamide 
(opening ”S” channels) in Aplvsia sensory neurones. 
It was therefore important to investigate if a cascade 
involving arachidonic acid plays a role in the 
FMRFamide induced slow response in the Cl neurone of 
Helix aspersa.
50pM arachidonic acid dissolved in 0.05% (v/v)
DMSO was applied to a Cl neurone (Figure 3.19). 
Throughout the duration of the experiment, 675 seconds 
(11.25 minutes), the amplitude of the FMRFamide 
responses and the level of the baseline current 
remained stable (n=3). The data from the experiment are
Figure 3.19
Arachidonic acid at a concentration of 50/üM 
dissolved in 0.05% (v/v) DMSO in normal saline did not 
influence the amplitude of the FMRFamide response of a 
Cl neurone voltage clamped at -45mV. Baseline current 
level was also unaffected. Arachidonic acid 
application is marked by the lines underneath the 
records. The time indicated above each record refers to 
the first FMRFamide response in that record relative to 
the starting time of arachidonic acid application (time 
zero). The arrows to the left of the records shows the 
position of the baseline current level at time zero. 
FMRFamide was administered at the points marked by the 
black dots.
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plotted in Figure 3.20. Since there was no mimic of, 
and no effect on, the FMRFamide response, the release 
of arachidonic acid and the subsequent production of I
its metabolites do not appear to be involved in the 
response.
3.8 IS THE FMRFamide RESPONSE DEPENDENT ON Ca2+?
The opening of certain K"*" channels requires the 
presence of Ca2 + on the intracellular surface of the 
neuronal membrane. Ca2 + ions may enter the neurone 
through channels from the extracellular environment or 
originate from intracellular stores of Ca^^. Since the 
discovery of Ca^*^ dependent channels in molluscan 
neurones by Meech, (1978) they have been shown to be 
widely distributed in excitable cells.
It was important to determine if the outward K^ " 
current induced by FMRFamide in the Cl neurone was Ca^^ 
dependent. Extracellular and intracellular Ca2+ 
concentrations were reduced by two different means 
described below. One or both of these approaches have 
been commonly utilized by other groups (Hammond et al 
1987, Sawada et al 1987, Paupardin-Tritsch and 
Gerschenfeld 1990).
3.8.1 THE EXTRACELLULAR DEPLETION OF Ca^+
The extracellular free Ca2+ concentration was 
effectively reduced to zero by perfusing the 
preparation with a modified saline where Mg 2 + were
•__ ' * ' I--'."' _ _ _ ■ - i . - _ _ _ _ _ _ _ t - i. Ï ' - ' ' "  - /'i.. , < ..-V, . . _. .
Figure 3.20
Data showing the lack of effect of 50/LtM 
arachidonic acid on the amplitude of the FMRFamide 
response (upper graph) or baseline current level (lower 
graph) for a Cl neurone voltage clamped at -45mV. The 
bars mark where 50^M arachidonic acid was applied. The 
level of the baseline current at time zero is marked by 
the dashed line on the lower graph.
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substituted for C&2+ and the Ca^ "** chelator EGTA was 
added (80mM NaCl, 5mM KCl, 9.5mM MgClg, 2itiM EGTA, 20mM 
Hepes, pH 7.5).
The recordings in Figure 3.21 show that when the 
0Ca2+ saline was applied to a Cl neurone, there was no 
change in the amplitude of the FMRFamide response over 
an 810 second (13.5 minute) period (n=4). Thus it 
appeared that the entry of Ca^^ into the neurone was 
not required for the production of the FMRFamide 
response.
The removal of external Ca^^ did induce an inward 
current, which was almost fully reversed on washing the 
preparation with normal saline (Figures 3.21 and 3.22, 
n=4). This inward current effect was not investigated 
further. However, it did suggest that Ca^^ dependent 
channels may normally be open at the holding potential 
of -45mV, although none were observed in patch clamp 
experiments.
3.8.2 REDUCTION IN INTRACELLULAR FREE Ca2+
CONCENTRATION
To further evaluate any possible contribution of 
Ca^ '*' in the FMRFamide response, intracellular Ca^^ 
concentration was reduced by injecting the Ca2 + 
chelator EGTA into the cell body of the Cl neurone.
EGTA was injected at a concentration of 700mM, which 
would have given an intracellular concentration of 0.7- 
7mM (see Methods). The EGTA itself was dissolved in a 
buffer solution which consisted of lOOmM KCl, 20mM
Figure 3.21
An experiment to show that OCa^^ saline had no 
effect on the amplitude of the FMRFamide response but 
did induce an almost fully reversible inward current in 
a Cl neurone voltage clamped at -4 5 mV. Application of 
0 Ca 2 + saline is marked by the lines underneath the 
records. The time marked above each record refers to 
the first FMRFamide response in that record relative to 
the start of 0 Ca 2 + application (time zero). The arrows 
to the left of the records show the position of the 
baseline current level at time zero. FMRFamide was 
applied at the points marked the black dots.
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Figure 3.22
Data showing the lack of effect of OCa^^ saline on 
the amplitude of the FMRFamide response of a Cl neurone 
voltage clamped at -45mV (upper graph). It did however, 
induce a reversible inward current (lower graph). 
Application of OCa^^ saline is marked by the bar on 
each graph. The baseline cuurent level at time zero is 
indicated by the dashed line on the lower graph.
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Hepes, 1% (w/v) fast green, pH 7.4 with KOH. This 
buffer solution was the same as that used with GTP*S 
injection. It had no effect on the FMRFamide response 
and induced a small inward current (Figure 3.3).
The data from an experiment where EGTA was 
injected into a Cl neurone are plotted in Figure 3.23.
It shows that after a 1800 second (30 minute) time 
period, there was no reduction in amplitude of the 
FMRFamide response (n=3). This is another indication |
that Ca2 + are not required for the production of the 
FMRFamide response.
Injection of EGTA did however, induce an inward 
current (approximately 0.8nA, n-3) which was much 
larger than that caused by the buffer solution alone 
(approximately O.lnA), again implying some inhibition 
of background activity of Ca^^ activated K"*" channels 
(as previously suggested (3.8.2)). It was not 
investigated further.
3.9 PROTEIN PHOSPHATASE INHIBITION BY QKADAIC ACID
Protein phosphatase enzymes have the role of 
dephosphorylating cellular proteins. The experiments 
described so far have been focussed on the activation 
of protein kinases by second messengers and a phorbol 
ester to increase protein phosphorylation levels. An 
alternative approach is to inhibit protein 
phosphatases. This has been made possible with the 
availability of substances such as okadaic acid.
Figure 3.23
EGTA injection at a concentration of 700mM into 
the cell body of a Cl neurone voltage clamped at -45mV 
had no significant effect on the amplitude of the 
FMRFamide response (upper graph). It did induce an 
irreversible inward current (lower graph). EGTA 
injection is indicated by the vertical arrow on each 
graph. The baseline current level at time zero is 
indicated by the dashed line in the lower graph.
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Okadaic acid is a polyether fatty acid which was 
first isolated from the marine sponges Halichondria 
okadaii and Halichondria melanodocia (Tachibana et 
al,1981). It was shown to be produced by several types 
of dinoflagellates and to be concentrated in filter 
feeding marine sponges. Clear evidence has indicated 
that okadaic acid is a very potent inhibitor of protein 
phosphatases in the cytosol of mammalian cells that 
dephosphorylate serine and threonine residues (Takai et 
al, 1987). Protein phosphatases 1 and 2A are both 
sensitive to okadaic acid. Of the other two major 
protein-serine/ threonine phosphatases, the 
Ca^^/calmodulin-dependent protein phosphatase 2B is 
markedly less sensitive, while the Mg2 + dependent 
protein phosphatase 2C is unaffected (Biolojan and 
Takaii, 1988). Since protein phosphatases 1, 2A and 2B 
have been identified in invertebrates (Orgad et al. 
1987; Fondaven and Cohen, 1987), it seemed reasonable 
to assume that okadaic acid would inhibit protein 
phosphatases 1 and 2A in the Cl neurone. Okadaic acid 
was originally dissolved in 100% DMSO and then diluted 
in normal saline to a concentration of 1/iM (0.01% DMSO 
(v/v)). Figure 3.24 shows the result of an experiment 
where l/uM okadaic acid was applied to a Cl neurone. 
After a 1200 second (20 minute) exposure to okadaic 
acid the amplitude of the FMRFamide response was 
reduced to approximately 15% of its original amplitude 
(n==3). This suggests that the FMRFamide response 
involves protein phosphorylation and that protein
1)iM okadaic acid
C
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Figure 3.24
Okadaic acid at a concentration of 1/iM dissolved 
in 0.01% (v/v) DMSO in normal saline reduced the 
amplitude of the FMRFamide response of a Cl neurone 
voltage clamped at -45mV. Okadaic acid application is 
marked by the bar.
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phosphatases 1 and/or 2 A may play a role in the 
dephosphorylation process.
3.10 SINGLE CHANNEL RECORDINGS
Recordings were made from cell attached patches on 
the Cl neurone. This procedure was useful since 
FMRFamide application out with the patch electrode 
could only have access to any ion channels within the 
patch of membrane via the production of an 
intracellular second messenger.
The term patch potential (Vp) is used to refer to 
the potential across the patch of membrane. The patch 
potential was calculated by subtracting the potential 
inside the pipette (Vpipette) f^rom the resting membrane 
potential (Vm) of the neurone:
Vp = Vm Vpipgtte
Vm was taken as -50mV since this was the average 
value observed from the intracellular recording 
experiments. Also, in cell attached patch experiments, 
where the membrane was inadvertently ruptured in an 
attempt to obtain a seal, the measured resting membrane 
potential was usually equal or close to -50mV.
With normal saline in the patch pipette (5mM K"*") 
unitary outward currents were observed at depolarized 
patch potentials. Only on one occasion were unitary 
outward currents seen at patch potentials close to the
8 7
resting membrane potential (1 out of 10 patches). The 
records from this patch are shown in Figure 3.25. The 
unitary current amplitudes are plotted against patch 
potential for this patch in Figure 3,26. The curve 
shown on the graph is a fit of the data points to the 
theoretical relationship from the GHK equation (Hodgkin 
and Katz, 1949) for a K"*" current, using the mean 
permeability value calculated from the data points. The 
mean permeability value was 1.68 x IQ-^^cm^s”^ . The 
intracellular concentration of K*^  was taken as 98mM 
(Alvarez-Leefmans and Gamino, 1982). The reversal 
potential of the relationship was approximately -70mV 
which is close to that predicted by the Nernst equation 
(-74mV) assuming that the intracellular K+ 
concentration is 98mM.
When the concentration in the patch pipette was 
reduced to ImM, the unitary outward currents became 
larger (at Vp ~20mV, 0.92pA with ImM K"*" compared to 
0.78 pA with 5mM K"^ ) as would have been expected for a 
current carried by K"**. Records of unitary currents made 
in such circumstances are shown in Figure 3.27 and 
again the current/voltage relationship is plotted with 
the theoretical curve for the GHK equation in Figure 
3.28. The average permeability constant calculated from 
the data points was 1.62 x lO^^^cm^s"!. This value is 
close to 1.68 X lorl^cm^s"! with 5mM K"^  in the patch 
pipette which indicates the same channel type being 
opened under both recording conditions.
When FMRFamide was applied to the neurones, the 
patch pipettes were filled with ImM K"^  saline so that
■V . " .‘ 1 t ' - , - ;   '3'-'':.. ... . ',f   I,. ; :_ _ ' , &
Figure 3.25
Records of unitary currents obtained from a cell 
attached patch on a Cl neurone held at various patch 
potentials. The patch potentials used are marked above 
the appropriate section of record. The recording 
solution in the patch pipette was normal saline which 
contained 5mM K"*".
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Figure 3.26
Current /voltage relationship of the unitary 
currents obtained from a cell attached patch on the Cl 
neurone with 5mM in the patch pipette. The line 
drawn through the points represents the theoretical 
relationship based on the GHK equation for a K"*" 
current. The permeability value of 1.68 x 10”^^cm^s-^ 
was calculated from the data points, assuming an 
intracellular K^ concentration of 98mM.
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Figure 3.27
Records of unitary currents obtained from a cell 
attached patch on a Cl neurone held at various patch 
potentials. The patch potentials used are marked above 
the appropriate section of recording. The patch pipette 
recording solution was a modified saline which 
contained ImM K"^ .
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Figure 3.28
Current /voltage relationship of the unitary 
currents obtained from a cell attached patch on the Cl 
neurone with ImM K"*" in the patch pipette. The line 
drawn through the points represents the theoretical 
relationship based on the GHK equation for a K"*" 
current. The permeability value of 1.62 x 10“^^cm^s“  ^
was calculated from the data points assuming an 
intracellular K"^  concentration of 98mM.
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any channels which may have been observed at a patch 
potential of -45mV (holding potential used in 
intracellular recording experiments) would be larger 
and easier to recognise. Figure 3.29a is a typical 
example of a recording where FMRFamide was applied to a 
Cl neurone outwith the membrane patch (n-30). Patches 
were obtained from several regions of the Cl neurone 
cell body. These patches showed no channel activity 
before or after the application of FMRFamide. FMRFamide 
was then washed from the preparation. A concern when 
FMRFamide did not induce channel activity was that no 
K"*" channels were actually present in that particular 
patch. To check if this was the case, the membrane 
patches were depolarized and with most of them (Figure 
3.29b) the presence of K"*" channels became apparent. 
Therefore FMRFamide application at a patch potential of 
-45mV did not open K"^  channels or influence the 
activity of the K"^  channels which had a permeability 
value of 1.62 X 10“^^cm^s“^.
3.11 THE FAST DEPOLARIZING FMRFamide RESPONSE OF THE C2
NEURONE
Fast depolarizing Na"^  current responses induced by 
FMRFamide have been found in three identified Helix 
aspersa neurones, namely the visceral El3, the right 
parietal F2 and the cerebral C2 neurones (Cottrell et 
ai, 1984; Cottrell and Davies, 1987; Cottrell et al  ^
1990). The response in the C2 neurone to FMRFamide was 
quite unique for a neuropeptide because it appeared to
Figure 3.29 a) and b)
Records from a cell attached patch on a Cl neurone 
showing that FMRFamide at a concentration of lOOjuM, did 
not open channels at a patch potential of -45mV. The 
recording solution in the patch pipette contained a 
modified saline with ImM concentration, a) The patch 
potential was held at -45mV. The time marked above 
three of the four sections of record is relative to the 
start of the application of FMRFamide (time zero). The 
second from top record shows the point at which 
FMRFamide was applied. The voltage record underneath 
shows that FMRFamide was applied by a pressure pulse 
which lasted 40ms. b) Unitary current record from the 
same cell attached patch at a depolarized patch 
potential of -20mV.
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be due to the direct activation of a ligand gated Na"*" 
channel (Cottrell et al , 1990). The purpose of the 
experiments described in the following sections was to 
further characterize this fast response.
3.11.1 GENERAL CHARACTERISTICS OF THE FAST Na+ RESPONSE 
IN THE C2 NEURONE
The depolarizing FMRFamide response of the C2 
neurone is relatively fast. This can be appreciated 
when experimental records are examined. Figures 3.30a 
and b show the response under current clamp and voltage 
clamp conditions. The average resting membrane 
potential of 40 neurones was -47mV. The average time 
taken between FMRFamide application and the maximum 
amplitude of the inward current response was 
approximately 2.5 seconds (Figure 3.30b). Since this 
response was appreciably faster than the slow 
hyperpolarizing K"^  response of the Cl neurone (average 
7 seconds) an expanded time scale was used.
When current clamped, the C2 neurone spiked 
continously. This feature was used to identify the 
neurone if there was any doubt of its position in the 
ganglion. On most occasions the neurone was located 
adjacent to the Cl neurone (Figure 2.2). With the 
addition of FMRFamide, the neurone was depolarized, an 
increase in spike frequency was observed and input 
resistance was reduced as indicated by the reduction in 
the size of the voltage deflections (Figure 3.30a).
1
Figure 3,30 a), b) and c).
The fast depolarizing response induced by 
FMRFamide in the C2 neurone under current and voltage 
clamp conditions, a) Current clamp recording of a 
neurone with a resting membrane potential (V^) of 
-50roV. The addition of FMRFamide caused a 
depolarization, an increase in the spike frequency and 
the amplitude of the voltage deflections initiated by 
constant hyperpolarizing current pulses was reduced. 
This was an indication of decreased input resistance, 
b) Voltage clamp recording from the same neurone at a 
holding potential of -75mV (V^). FMRFamide application 
induced an inward current associated with a decreased 
input resistance as indicated by the increased size of 
the current deflections initiated by a constant 
hyperpolarizing voltage step, c) Voltage clamp 
recording of a neurone which was held at -75mV. 
FMRFamide applications which were made in rapid 
succession desensitized the response. In a), b) and c) 
FMRFamide application is marked by the black dots.
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Figure 3.30c shows that repeated applications of 
FMRFamide over a short period of time resulted in the 
desensitization of the response.
The FMRFamide response/voltage relationship of the 
C2 neurone is shown in Figure 3.31. The amplitude of 
the inward current reponses became larger at more 
negative potentials and smaller at more depolarized 
potentials. The relationship of current response 
against voltage was not linear but inwardly rectifying 
as would be expected from the constant field equation.
This describes the movement of an individual ionic *
species across the membrane by simple diffusion along a 
constant potential gradient. Data points on the curve 
were only obtained up to a holding potential of -5mV. 
This was because any further depolarization resulted in 
the appearance of interfering axon spikes, voltage 
activated currents and high frequency oscillations 
of the voltage clamp. However, the values obtained 
suggested that the reversal potential of the response 
occurred at a more depolarized potential than OmV 
(Figure 3.31).
3.12 CHARACTERIZATION OF THE FMRFamide INDUCED FAST 
DEPOLARIZING RESPONSE OF THE C2 NEURONE.
3.12.1 ONa+ SALINE
C2 neurones were voltage clamped at -75mV (more 
hyperpolarized than resting membrane potential) to 
obtain larger responses and FMRFamide was applied every
100-80 -60 -40 -20 ^-40 60 80
Figure 3.31
A plot of the current reponse/voltage relationship 
of the fast depolarizing FMRFamide response in the C2 
neurone.
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30 seconds. The upper experimental recording in Figure 
3.32 shows that FMRFamide responses of regular 
amplitudes were obtained. The neurone was then exposed 
to a perfused saline to which no NaCl had been added 
(the NaCl had been replaced by sucrose, therefore it 
was termed as a ONa+ saline). Within 60 seconds of 
exposure to the ONa*^ saline, the FMRFamide response had 
been reduced considerably (0.95nA to 0.19nA). When the 
neurone was exposed to normal saline again, the t
response recovered although not back to its original |
amplitude (n=3). The data of the experiment are plotted f
in Figure 3.33. This result confirmed that Na"^  was the 4Imain charge carrier for the FMRFamide response.
i
3.12.2 C0 CI2 ;
;ICoClg was applied to the C2 neurone as a simple
method to block Ca2+ channels (Akaike et al , 1981) and i\
hence determine if Ca^ "*" had a role in the production of
the FMRFamide response. Figure 3.34 shows a recording
where a 02 neurone held at -75mV was responding ;
constantly to FMRFamide. Exposure of the neurone to ImM ^■1C0 CI 2 had no effect on the amplitude of the response 
(n=3). When the response amplitude is plotted against 
time (Figure 3.35) it can be clearly seen that ImM 
CoClg had no effect even after a 600 second ( 1 0  
minutes) application. Therefore, a possible involvement 
of Ca 2 + in the response was eliminated.
Figure 3.3 2
The application of ONa+ saline reduced the 
amplitude of FMRFamide responses obtained from a C2 
neurone held at ~75mV. The response reversed to some 
extent on washing with normal saline. The time marked 
above each record refers to the first FMRFamide 
response in that record relative to the start of ONa+ 
saline application (time zero). FMRFamide was applied 
at the points marked by the black dots.
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Figure 3.3 3
Data showing the effect of applying ONa^ saline to 
a C2 neurone voltage clamped at -75mV. This saline 
reduced the amplitude of the FMRFamide response, an 
action which was almost fully reversible. ONa"*" saline 
application is marked by the bar.
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10s
Figure 3.3 4
An experiment showing that normal saline 
containing ImM C0 CI2 had no effect on the amplituide of 
the FMRFamide response in a C2 neurone voltage clamped 
at -75mV. The administration of C0 CI2 is marked by the 
lines underneath the records. The time marked above 
each record refers to the first FMRFamide response in 
that record relative to start of C0 CI2 application 
(time zero). FMRFamide was applied at the points marked 
by the black dots.
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Figure 3.3 5
Data showing that ImM C0 CI2 application to a C2 
neurone held at -75mV had no effect on the amplitude of 
the FMRFamide response. The application of C0 CI2 is 
marked by the bar.
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3.12.3 TETRODOTOXIN fTTX)
Since it had been established that Na^ was the 
main charge carrier in the FMRFamide inward current 
response, the next stage was to determine whether the 
response could be blocked by drugs which are known to 
block Na"^  conductances.
TTX was used because its action is highly 
specific. When working with squid axons, Moore and 
coworkers in 1967 showed that TTX blocked the voltage 
sensitive Na"^  conductance selectively. For TTX to have 
any effect it must be applied outside the cell 
membrane.
Exposure of a C2 neurone to 50/iM TTX did not 
reduce the amplitude of the FMRFamide response for 1200 
seconds (20 minutes) (Figure 3.36, n=3). The data are 
represented in graphical form in Figure 3.37.
3.12.4 LIGNOCAINE
When local anaesthetics such as lignocaine are 
applied to nerves they increase the threshold for 
electrical stimulation, slow the rate of rise of the 
action potential and slow the rate of conduction. It is 
known that these drugs prevent the transient increase 
in Na"^  permeability that is essential for generating 
the rising phase of the spike potential in response to 
a depolarizing current (Covino, 1971; Lechat, 1971).
Application of ImM lignocaine to a C2 neurone 
voltage clamped at -75mV had no effect on the amplitude
Figure 3.36
When 50^M TTX was applied to a C2 neurone voltage 
clamped at -75mV, there was no effect on the amplitude 
of the FMRFamide response. The time shown above each 
record refers to the first FMRFamide response in that 
record relative to the start of TTX application (time 
zero). The lines underneath the records show where TTX 
was applied. FMRFamide was pulsed onto the neurone at 
the points marked by the black dots.
90s
630s
#
50|iM TTX
1110s
e
50pMTTX
Vh -75mV
50pM TTX
O.SnAL
10s
a
1.0 -
0.9 -
0.8 -
0.7-
0.6 -
SO^iM TTX0.5 -
Q. 0.4 -
0.3 -
0.2 -
0.0
1000 1200800200 400 600200 0
Time (secs)
1
Figure 3.37
Data showing the lack of effect of 50/iM TTX on the 
amplitude of the FMRFamide response of the C2 neurone 
voltage clamped at -75mV. Application of TTX is marked 
by the bar.
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of the FMRFamide response (Figure 3.38) over a period 
of 810 seconds (13.5 minutes) as is shown in Figure 
3.39 (n=2).
3.12.5 AMILORIDE
Amiloride is a specific and very potent inhibitor 
of Na"^  transport in a wide variety of epithelial and 
cellular transport systems throughout the animal 
kingdom (Benos, 1982). It is a drug which acts rapidly 
and reversibly and is used clinically as a sparing 
diuretic (Benos, 1982).
Amiloride was applied to the C2 neurone to see if 
it would inhibit the FMRFamide induced, fast Na"^  
response. The experimental records in Figure 3.40 show 
that 100/iM amiloride rapidly (within 60 seconds) almost 
completely blocked the FMRFamide response (n=5). This 
effect of amiloride was almost fully reversible as can 
be seen when amiloride was no longer present. The data 
from the experiment are illustrated in Figure 3.41. Of 
all the drugs tested, amiloride gave the most effective 
and reversible block.
3.13 EFFECT OF CYCLIC AMP ON THE FMRFamide RESPONSE OF
THE C2 NEURONE
In a recent study by Song and Huang (1990), the 
modulation of glycine receptor channels by cyclic AMP 
dependent protein kinase A in neurones isolated from 
the spinal trigemal nucleus of the rat was examined.
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Figure 3.38
The application of ImM lignocaine to a C2 neurone 
voltage clamped at -75mV had no effect on the amplitude 1 
of the FMRFamide response. Lignocaine application is 
marked by the line underneath the lower record. The 
time shown above each record refers to the first 
FMRFamide response in that record relative to the start ; 
of lignocaine application (time zero). FMRFamide was 
pulsed onto the neurone at the points marked by the 
black dots.
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Figure 3.3 9
Data showing the lack of effect of ImM lignocaine 
on the amplitude of the FMRFamide response of a C2 
neurone which was voltage clamped at -75mV. The 
application of lignocaine is marked by the bar.
Figure 3.40
Amiloride at a concentration of lOOjuM reversibly 
reduced the amplitude of the FMRFamide response of a C2 
neurone voltage clamped at -75mV. Amiloride application 
is marked by the lines underneath the upper and middle 
records. The time shown above each record refers to the 
first FMRFamide response in that record relative to the 
start of amiloride application (time zero). FMRFamide 
was pulsed onto the neurone at the points marked by the 
black dots.
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Figure 3.41
Data showing that lOOjuM amiloride application 
reversibly reduced the amplitude of the FMRFamide 
response of a C2 neurone voltage clamped at ~75mV. 
Amiloride application is marked by the bar.
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They found that activation of cyclic AMP dependent 
protein kinase dramatically increased the glycine 
induced Cl"“ currents by increasing the probability of 
the channel openings. A Gg protein was also involved in 
the modulation. It was suggested that glycine receptors 
may belong to a superfamily of chemically gated channel 
proteins of which the GABA^ ^^  and nicotinic ACh receptors 
belong. Cottrell and coworkers (1990) have shown that 
the FMRFamide induced fast Na^ response of the 02 
neurone is due to the opening of a ligand gated 
channel. Therefore it was important to determine if 
this channel was also modulated by cyclic AMP and 
protein phosphorylation. Membrane soluble analogues of 
cyclic AMP were used in the experiments described 
below.
3.13.1 DIBUTYRYL CYCLIC AMP
Dibutyryl cyclic AMP was the first analogue to be 
used. When this substance at a concentration of ImM was 
applied to a C2 neurone, there was a rapid (within 150 
seconds) increase in amplitude of the response (n=5) 
and a slight inward movement of the baseline current 
level. This can be seen by comparing the upper and 
middle records of Figure 3.42. When dibutyryl cyclic 
AMP was washed away (lower record Figure 3.42), the 
FMRFamide responses returned to their original 
amplitude and the baseline membrane current also 
returned to its original level. The data from the 
experiment are plotted in Figure 3.43. The inward
Figure 3.42
The application of ImM dibutyryl cyclic AMP to a 
C2 neurone voltage clamped at -45mV reversibly 
potentiated the amplitude of the FMRFamide response. It 
also induced a very small inward baseline current. 
Dibutyryl cyclic AMP application is marked by the line 
underneath the middle record. The time marked above 
each record refers to the first FMRFamide response in 
that record relative to the start of dibutyryl cyclic 
AMP application (time zero). The arrows to the left of 
the records show the level of the baseline current at 
time zero. FMRFamide was pulsed onto the neurone at the 
points marked by the black dots.
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Figure 3,43
Data showing that the application of ImM dibutyryl 
cyclic AMP to a C2 neurone voltage clamped at -45mV 
reversibly potentiated the amplitude of the FMRFamide 
response (upper graph). It also produced a small 
reversible inward current (lower graph). Dibutyryl 
cyclic AMP application is shown by the bar on each 
graph. The level of the baseline current at time zero 
is marked by the dashed line on the lower graph.
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current induced by dibutyryl cyclic AMP was not j
investigated further. f
3.13.2 8-f-4l CPT CYCLIC AMP
When the more potent membrane soluble analogue of 
cyclic AMP, 8 -(-4) CPT cyclic AMP was used at a 
concentration of ImM, the rapid increase in the 
amplitude of the FMRFamide response was even more 
pronounced (upper and middle records Figure 3.44). The 
analogue also produced an inward current which was 
larger than the dibutyryl cyclic AMP induced inward 
current. When the 8-(-4) CPT cyclic AMP was washed from 
the preparation (lower record Figure 3.44), the 
amplitude of the FMRFamide responses and the baseline 
membrane current returned to their original levels. The 
data from the experiment are plotted in Figure 3.45.
3.13.3 CYCLIC AMP
When using membrane soluble analogues of cyclic 
AMP at high concentrations, it was important to 
determine if the increase in the FMRFamide response 
might be due to some external, non-specific action of 
these substances. To test this possibility, cyclic AMP 
itself, which is not membrane soluble, was applied at a 
ImM concentration to the C2 neurone. The data of an 
experiment are shown in Figure 3.46. Cyclic AMP had no 
significant effect on the amplitude of the FMRFamide 
response or the baseline membrane current. Therefore,
i
Figure 3.44
When ImM 8 -(-4) CPT cyclic AMP was applied to a C2 
neurone voltage clamped at -45mV, the amplitude of the 
FMRFamide response was reversibly potentiated. An 
almost fully reversible inward baseline current was 
also induced. 8-(-4) CPT cyclic AMP application is 
marked by the lines underneath the upper and middle 
records. The time marked above each record refers to 
the first FMRFamide response in that record relative to 
the start of 8-(-4) CPT cyclic AMP application (time 
zero). The arrows to the left of the records show what 
was the position of the baseline current level at time 
zero. FMRFamide was pulsed onto the neurone at the 
points marked by the black dots. The rapid inward 
current deflections represent undamped axon spikes.
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Figure 3.45
Data showing ImM 8~(-4) CPT cyclic AMP reversibly 
potentiated the amplitude of the FMRFamide response of 
a 02 neurone which was voltage clamped at -45mV (upper 
graph). An almost fully reversible inward current was 
also induced (lower graph). 8-(-4) CPT cyclic AMP 
application is shown by the bar on each graph. The 
level of the baseline current at time zero is marked by 
the dashed line on the lower graph.
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Figure 3.46
These data show that ImM cyclic AMP application to 
a C2 neurone voltage clamped at -45mV had no effect on 
the amplitude of the FMRFamide response (upper graph) 
or the baseline current level (lower graph). The bar on 
each graph represents the application of cyclic AMP.
The level of the baseline current at time zero is 
marked by the dashed line on the lower graph.
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it appears that the effects of the membrane soluble 
analogues were due to intracellular action rather than 
an extracellular action.
3.13.3 IBMX
The phosphodiesterase inhibitor IBMX was applied 
to the C2 neurone. Since IBMX inhibits the breakdown of 
cyclic nucleotides, this was another means of raising 
the intracellular cyclic AMP levels. As was expected, 
exposure of the C2 to ImM IBMX (n-3) led to an increase 
in amplitude of the FMRFamide response and the 
production of an inward current (see Figures 3.47 and 
3.48). This was a mimic of the membrane soluble cyclic 
AMP analogue effects.
3.13.4 8-f-4l CPT CYCLIC AMP AND OKADAIC ACID
With the potentiation of FMRFamide response by the 
membrane soluble analogues of cyclic AMP having been 
established, it was important to determine if this 
occurred by increased protein phosphorylation due to 
cyclic AMP dependent protein kinase A activation. This 
was approached by applying the protein phosphatase 1  
and 2A inhibitor, okadaic acid along with 8-(-4) CPT 
cyclic AMP to the 02 neurone. The idea was that if the 
potentiation of the FMRFamide response induced by 8 -(- 
4) CPT cyclic AMP was due ultimately to increased 
protein phosphorylation, okadaic acid at a high
Figure 3.47
The application of ImM IBMX to a C2 neurone 
voltage clamped at ~7 3mV reversibly potentiated the 
amplitude of the FMRFamide response. It also induced a 
reversible inward current. IBMX application is shown by 
the line underneath the middle record. The time marked 
above each record refers to the first FMRFamide 
response in that record relative to the start of IBMX 
application (time zero). The arrows on the left of the 
records indicate the original baseline current level at 
time zero. FMRFamide was pulsed onto the neurone at 
points marked by the black dots.
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Figure 3.48
Data showing that ImM IBMX application to a C2 
neurone voltage clamped at ~73mV caused the reversible 
potentiation of the amplitude of the FMRFamide response 
(upper graph) and also produced a reversible inward 
baseline current (lower graph). IBMX application is 
marked by the bar on each graph. The original level of 
the baseline current at time zero is indicated on the 
upper graph by the dashed line.
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concentration (1/LtM) would prevent protein 
dephosphorylation and hence maintain the potentiation 
even in the absence of 8-(-4) CPT cyclic AMP.
Figure 3.49 shows that when ImM 8 -(-4) CPT cyclic 
AMP and 1/iM okadaic acid were applied together to a C2 
neurone, a familiar potentiation of the amplitude of 
the FMRFamide response was produced. However, when the 
neurone was then washed with 1/xM okadaic acid only, the 
amplitude of the FMRFamide response reduced back 
towards control levels (n=3). The data obtained in the 
experiment are presented graphically in Figure 3.50.
■Î
Figure 3.49
The application of a combination of ImM 8 -(-4) CPT 
cyclic AMP & 1/iM okadaic acid potentiated the amplitude 
of the FMRFamide response of a voltage clamped C2 
neurone ( -75mV). It also induced an inward movement 
of the baseline current level. A following wash with 
1/iM okadaic acid reversed the two effects detailed 
above. 8 -(-4) CPT cyclic AMP & okadaic acid application 
and okadaic acid alone are marked by the lines 
underneath the records. The time marked above each 
record refers to the first FMRFamide response in that 
record relative to the start of the 8 -(-4) CPT cyclic 
AMP/okadaic acid application (time zero). The arrows on 
the left of the records indicate the original baseline 
current level at time zero. FMRFamide was pulsed onto 
the neurone at the points marked by the black dots.
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Figure 3.50
Data showing that the combined application of ImM 
8 -(-4) CPT cyclic AMP & l^M okadaic acid produced a 
potentiation of the amplitude of the FMRFamide response 
in a 02 neurone voltage clamped at -75mV (upper graph). 
This combination also induced an inward current (lower 
graph) . Both effects were reversed on washing with 1/iM 
okadaic acid. The application of the 8 -(-4) CPT cyclic 
AMP & 1/iM okadaic acid mixture and 1/iM okadaic acid 
alone are marked by the bars on each graph. The 
original position of the baseline current level at time 
zero is indicated on the lower graph by the dashed 
line.
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4.1 GENERAL PROPERTIES OF THE FMRFamide RESPONSES
The purpose of the studies detailed in this thesis 
has been to examine two different effects of FMRFamide 
on identified molluscan neurones. The application of 
FMRFamide to the cell bodies of these neurones probably 
stimulates extra-synaptic receptors, since molluscan 
synapses are usually axo-axonic. Not only does 
FMRFamide induce currents carried by two separate 
cations, one K"*’ and the other Na+, the profiles of the 
responses are also quite different. The K"*" current 
induced by FMRFamide in the Cl neurone is slow (7 
seconds between application and maximal response) 
whilst the Na"^  current is relatively fast (2.5 seconds 
between application and maximal response). Such 
differences illustrate the diversity of action of 
FMRFamide related peptides on nervous tissue. The 
FMRFamide related peptides may act as neurotransmitters 
and also have a neurohormonal role.
4.2 THE SLOW K+ CURRENT INDUCED BY FMRFamide IN THE Cl
NEURONE
Previous studies have shown conclusively that the 
hyperpolarizing current induced by FMRFamide in the Cl 
neurone of Helix aspersa is carried by K**" (Cottrell et 
al, 1984). The reversal potential obtained from the 
current response/voltage relationship (Figure 3.2) 
supports this finding. The reversal potential recorded 
was -70mV which is close to that predicted by the
'
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Nernst equation (-75mV) for a conductance carried by 
alone. The intracellular concentration of was 
assumed to be 98mM (Alvarez-Leefmans and Gamino, 1982). 
One of the main questions addressed in this thesis is, 
what is the mechanism by which FMRFamide opens the K"*" 
channels? The fact that the response is slow implies 
that there is a considerable delay between FMRFamide 
receptor activation and channel opening. This suggests 
that activation of an intracellular second messenger 
system may underlie the FMRFamide response.
4.2.1 G PROTEIN INVOLVEMENT
G proteins are proteins housed in cell membranes 
which mediate signal transduction by interacting with 
receptor proteins. G proteins are structurally 
heterogeneous. They are heterotrimers made up of a , R  
and ^ subunits. The J3 and iT subunits are closely 
associated with each other. This R'g complex is thought 
to anchor the G protein to the plasma membrane (Bourne,
1986).
When G proteins are inactive, GDP is bound to the 
catalytic site of GTPase localized in the a subunit.
The conformational change of a receptor induced by 
agonist binding influences the coupling G protein to 
release the bound GDP. Intracellular GTP then binds to 
the same site where it is hydrolysed by the GTPase. 
While this process of hydrolysis is taking place, the a
J:
subunit dissociates from the R i  subunits. The a subunit J
reassociates with the subunits to form a more stable '
100
conformation when GDP reoccupies the GTPase site. The 
non-hydrolysable GTP analogue, GTPfS, is therefore able 
to irreversibly activate G proteins.
When GTP*S was injected into the cell body of the 
Cl neurone, two clear effects were observed. Firstly, 
GTPfS induced an outward current, which increased as a 
function of time. This outward current was due to an 
increase in membrane conductance. Secondly, the 
FMRFamide responses were reduced as the outward current 
associated with GTPfS took effect. In other words, the 
responses to FMRFamide were occluded by the outward 
current. At the end of the experiments the outward 
current associated with GTPfS was almost equal to the 
amplitude of the control FMRFamide responses. The 
responses to FMRFamide obtained prior to injection of 
GTPUS in the experiment shown in Figure 3.4 were large 
(2.4nA) and close to maximum. The final level of the 
baseline current may have indicated a complete open 
state of almost all K'*' channels, coupled with the total 
number of FMRFamide receptors in the neuronal cell 
body. This would have resulted in the occlusion of the 
FMRFamide responses. The effects of GTP*S provide good 
evidence that G protein activation is required for the 
slow FMRFamide response in the Cl neurone.
The next stage was to examine what type of G 
protein was involved. Three broad groups of G proteins 
are recognised. Gg, G proteins which stimulate 
adenylate cyclase, G^, G proteins which inhibit 
adenylate cyclase and Gq , G proteins which do not 
influence adenylate cyclase (Birmbaumer et al, 1990;
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Taylor, 1990). The bacterial toxin pertussis toxin 
(PTX) has a protomer subunit which has an adenosine 
diphosphate (ÀDP) ribosetransferase. This bacterial 
toxin can ADP-ribosylate a subunits of and Gq G 
proteins. The ADP ribosylation by PTX occurs at the 
cysteine residue of these a-subunits and uncouples 
these G proteins from their receptors (Hsia et al 1984;
Ui, 1984; Van Drop et a l , 1984). PTX does not impair 
GTPase activity at the a subunit of Gj^  or Gp.
When PTX in its active form was injected into a Cl 
neurone, the FMRFamide responses were reduced. This 
evidence suggested that the G protein involved in the 
FMRFamide response was of the G^ or Gq type.
These results compare favourably with experiments 
performed by workers interested in the modulation of 
ion channels. Brezina (1988) using GTPfS injections 
showed that FMRFamide activates an *'S” like K"*" current 
by a mechanism involving a G protein in abdominal 
ganglion neurones of Aplysia. Sasaki and Sato (1987) 
and Sasaki et al, (1987) showed that K"** channel 
openings induced by ACh, dopamine, histamine and 
FMRFamide were all produced via the activation of PTX 
sensitive G proteins.
4.2.2 CYCLIC AMP AND 5-HT
Membrane soluble analogues of cyclic AMP were used 
to mimic an intracellular rise in concentration of this 
second messenger. When 8-(-4) CPT cyclic AMP was *
applied to Cl neurones there were two clear effects,
- I-. -   - • . ; - -n--./- /'_________________________________ _ . . . JXÀl. •- V ”<■-ü ''L. i ! . ... . . .
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Firstly, there was a steady reduction in the amplitude 
of FMRFamide responses until they were completely 
suppressed. Secondly, there was an inward movement of 
the baseline current level, which was associated with 
increased membrane conductance. There was certainly no 
mimic of the FMRFamide responses. This indicated that 
the receptor activated increase of cyclic AMP levels 
was not the mechanism underlying the FMRFamide 
response. Application of the phosphodiesterase 
inhibitor IBMX, which prevents the breakdown of both 
cyclic AMP and cyclic GMP also reduced the amplitude of 
the FMRFamide response and induced an inward current.
The action of 5-HT appears to be important in relation
‘.4to the above results. 5-HT induced an inward current |
and reduced the amplitude without complete suppression |
of the FMRFamide responses. Since the actions of 5-HT i
and raised cyclic AMP levels were similar it seemed i|
reasonable to suggest that 5-HT, operating through the I
production of cyclic AMP, may be responsible for the 
observed effect. The likelihood of this being the case j
was enhanced by the results obtained from experiments ,I
where a mixture of IBMX and 5-HT were applied to the ^
neurones. Compared to 5-HT application alone, 5-HT with 
IBMX produced a greater reduction in the amplitude of 
the FMRFamide response and the response took 
considerably longer to recover when the compounds were |
washed from the neurones. The inward currents induced 
by 5-HT and IBMX were of increased magnitude and took a -4
greater time to recover. 1
103
Brezina et al (1987a) performed similar 
experiments on Aplysia abdominal ganglion neurones. The 
results reported agree with some of the observations 
made with Cl neurone. Direct injection of cyclic AMP 
and extracellular application of compounds which raise 
cyclic AMP levels, reduced the increase in K"*" 
conductance induced by FMRFamide in these Aplvsia 
neurones. 5-HT application also reduced the FMRFamide 
responses, an effect which was enhanced in the presence 
of R020-1724, a cyclic AMP phosphodiesterase inhibitor. 
The injection of cyclic AMP also induced an inward 
current which was Na*^  dependent. Intracellular 
injection of cyclic AMP has been shown to induce slow 
inward currents in many gastropod molluscs. It was 
therefore not surprising that treatments designed to 
increase intracellular cyclic AMP levels in the Cl 
neurone and Aplysia neurones induced inward currents 
due to increased membrane conductances. The inward 
current varies from one species to another. In neurones 
of Pleurobranchaea californica (Gillette and Green,
1987), Lvmnea staanalis (McCrohan and Gillette, 1988) 
and Arachidoris montereyensis (Connor and Hockberger, 
1984), it is carried purely by Na+. In Aplysia 
californica it is carried by Ca%+ (Pellmar, 1981) and 
in Limax maximus it is carried by both Na"^  and Ca+ 
(Hockberger and Connor, 1984).
When Brezina et al (1987a) performed patch clamp 
studies on pleural ventrocaudal neurones, which 
responded in the same manner to FMRFamide as the 
abdominal ganglion neurones, the results differed from
■*  ^  Cr-.-In 4 »■ • " " ' ''■■4r ' JC' I.
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those obtained with the Cl neurone. With the Aplysia 
neurones, 5-HT caused the closure of background K+ 
channels in cell attached patches, while FMRFamide 
enhanced the activity of these channels. FMRFamide did 
not appear to recruit previously silent channels and 
patch studies confirmed the idea that the channels 
sensitive to 5-HT and FMRFamide were ”S" type K*** 
channels.
Patch clamp studies on the Cl neurone using cell 
attached patches showed that at patch potentials close 
to the resting membrane potential (Vp-45mV), there was 
no background channel activity. When FMRFamide was 
applied to these patches there was no sign of channel 
openings. Therefore, it is not clear whether the 
outward current induced by FMRFamide on the Cl neurone 
is due to the opening of genuine ”S" type channels 
or to some other as yet undefined K"^  channel.
4.2.3 CYCLIC GMP
Application of the membrane soluble analogue of 
cyclic GMP, 8 -bromo cyclic GMP to Cl neurones produced 
an inward current. The inward current was not studied 
in any detail. The amplitude of the FMRFamide responses 
was not influenced by the analogue. From this it was 
concluded that elevated levels of cyclic GMP could be 
ruled out as the second messenger which underlies the 
response.
The result obtained with cyclic GMP made it 
possible to clarify a point which arose from the
1
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effects of IBMX, IBMX application reduced the amplitude 
of the FMRFamide responses, which could have been due 
an increase in the levels of cyclic AMP, cyclic GMP or 
both. However, since increased cyclic GMP levels had no 4
effect on the amplitude of the FMRFamide response it 
became clear that the action of IBMX was due only to 
increased cyclic AMP levels.
Cyclic GMP has been shown to be an important 
second messenger underlying the effects of FMRFamide on 
the abdominal ganglion neurone R14 of Aplysia (Ichinose 
and McAdoo, 1988). In this neurone, FMRFamide induces a 
slow depolarizing response which is due to an inward 
current carried by Na+. Intracellular injections of 
cyclic GMP into the R14 neurone mimicked the FMRFamide 
response. IBMX enhanced the effects of cyclic GMP and 
FMRFamide.
Cyclic GMP has also been shown to be involved in 
the 5-HT induced increase in Ca^^ membrane conductance 
in identified ventral neurones of Helix aspersa 
(Paupardin-Tritsch et a l . 1986a and b). Injection of 
cyclic GMP or extracellular application of zaprinast, a 
cyclic GMP phosphodiesterase inhibitor, both mimicked 
the effect of 5-HT. Also, injection of cyclic GMP 
dependent protein kinase potentiated the actions of 5- 
HT or zaprinast on the Ca^^ current. Therefore, raised 
cyclic GMP levels activating cyclic GMP dependent 
protein kinase is an important mechanism mediating the 
action of 5-HT on these neurones.
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4.2.4 INOSITOL 1,4,5-TRISPHOSPHATE
Streb et al (1983) reported that the second 
messenger IP3 released 0 3 ^+ from an intracellular non- 
mitochondrial store. This Ca^^ store was found to be 
the endoplamic reticulum (Streb et al, 1984; Prentki et 
al, 1984).
To examine if the production of IP3 was involved 
in the FMRFamide response of the Cl neurone, IP3 was 
injected directly into the cell body. IP3 applied in 
this way had no effect on the baseline current level. 
Since there was no mimic of the FMRFamide response this 
apparently ruled out the involvement of IP3 .
À number of studies have shown that IP3 is likely 
to play a role as an intracellular second messenger 
mediating the increase in conductance of the neuronal 
membrane activated by neurotransmitters. Amongst these, 
the peptide bradykinin which induces inositol lipid 
breakdown, has attracted a great deal of attention 
because electrophysiological studies of this receptor- 
mediated event demonstrated the involvement of 
phosphoinositide metabolites in neuronal transmission. 
It was found that intracellular injection of IP3 or 
Ca2 + mimicked the transient hyperpolarization induced 
by bradykinin in neuroblastoma X glioma hybrid NG108-15 
cells (Higashida and Braun, 1986). Oron and coworkers 
(1985) have shown that injection of IP3 into a Xenopus 
oocyte mimicked a muscarinic depolarizing Cl“ current.
107
hence implicating IP3 as the second messenger mediating 
the response.
IP3 has also been shown to have important effects 
on molluscan neurones. Fink and coworkers (1985) 
demonstrated that intracellularly injected IP3 
hyperpolarized the petidergic bag cell neurones of 
Aplysia. and caused a reduction in the action 
potentials evoked by depolarizing current. Also, 
injection of IP3 into identified abdominal ganglion 
neurones of Aplysia induced an outward, hyperpolarizing 
current (Sawada et al , 1987).
4.2.5 PROTEIN KINASE C
Protein kinase C activation in the Cl neurone was 
achieved by applying a tumour promoting phorbol ester, 
phorbol 12,13-dibutyrate. Protein kinase C activation 
did not mimic the FMRFamide response hence ruling out 
the possibility of its direct involvement in producing 
the response. However, application of the phorbol ester 
did induce a reversible inward current and an 
irreversible reduction of the amplitude of the 
FMRFamide response. The inward current was not studied 
in detail. It is possible however, that the observed 
inward current with the phorbol ester, is related to 
larger inward currents seen at more depolarized 
potentials (less than -45mV) when 5-HT induces closure 
of voltage dependent K"*" channels in the Cl neurone.
This effect of 5-HT has been shown to be mediated by 
protein kinase C and protein phosphorylation
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(Hill-Venning and Cottrell, 1988; Cohen et al. 1989).
At potentials less negative than -45mV FMRFamide is 
also thought to close the same voltage dependent K"*" 
channels as 5-HT (Davies, 1986).
The reduction in the amplitude of the FMRFamide 
response indicated that protein kinase C activation may 
in some way modulate the response. This finding falls 
in line with some other studies. For example, in 
hippocampal pyramidal neurones adenosine, baclofen and 
5-HT induce a current which causes hyperpolari­
zation. Pertussis toxin inhibited the action of these 
agonists which suggested that they operated through the 
activation of a or Gq protein. When phorbol esters 
were applied to these neurones the responses were 
blocked, which indicated that protein kinase C 
activation might be able to inhibit the G protein that 
couples the receptors to the ion channels (El-Fakahany 
et al. 1988). It had been previously been shown with 
platelets that the activation of protein kinase C leads 
to the phosphorylation and inactivation of a Gj^  protein 
(Katada et al, 1985).
Since it has been shown that the FMRFamide 
response in the Cl neurone is mediated through a Gj^  or 
Gq protein, it is possible that protein kinase C 
activation could phosphorylate the G protein and cause 
its inactivation. However, the reason for the 
irreversible nature of this effect when the phorbol 
ester has been washed away is unclear.
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4.2.6 0Ca2+ EXPERIMENTS
Experiments were performed to examine if Ca^^, 
either entering the neurone from the extracellular 
environment through Ca^^ channels or being released 
from intracellular stores, are required for the 
generation of the FMRFamide response, Ca^^ 
concentrations were reduced either by injecting the 
Ca2+ chelator EGTA into the cell body of the neurone, 
or by removing Ca^^ from the perfusing saline. Both of 
these approaches produced quite a large, prolonged 
inward current. The effect was reversible in the 0Ca2+ 
saline experiments upon washing with normal saline. The 
shift in background current in an inward direction may 
have been due to the closure of Ca^^ dependent K"*" 
channels. Neither treatment however, altered the 
amplitude of the FMRFamide response on the Cl neurone. 
The FMRFamide response can therefore be considered as 
Ca2 + independent.
This result falls into line with that obtained 
from the injection of IP3 , IP3 injection, which has the 
role of releasing Ca^^ from intracellular non- 
mitochondrial stores into the cytosol, had no direct 
involvement in the FMRFamide response. The result also 
confirms that obtained with protein kinase C 
activation, which showed that this enzyme is not 
directly involved in the FMRFamide response. Activation 
of protein kinase C depends upon the presence of Ca^^ 
(El-Fakahany et al, 1988). If the FMRFamide response
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had depended on protein kinase C activation, the 
reduction in Ca^^ concentration would have been 
expected to reduce the FMRFamide response.
4.2.7 ARACHIDQNIC ACID
The second messenger arachidonic acid and its 
metabolites have been shown to mediate the FMRFamide 
action of increasing "S" K"*" channel openings in sensory 
neurones of Aplysia. Application of arachidonic acid to 
these sensory neurones was shown to mimic the FMRFamide 
response (Piomelli et al, 1987). The effect of 
FMRFamide on these neurones has been shown to be 
mediated by two separate actions: a) In the presence of 
basal cyclic AMP levels the FMRFamide induced increase 
in "S" channel open probability (Belardetti et a l . 
1987) occurs through the activation of the 12- 
lipoxygenase arachidonic acid breakdown pathway. 1 2 - 
HPETE was the active metabolite of this pathway and its 
application to sensory neurones mimicked the FMRFamide 
response (Piomelli et al. 1987). It has now been 
suggested that 12-HPETE requires further metabolism to 
cause the opening of the "S" K"^  channels (Piomelli et 
al, 1989). These actions of FMRFamide and arachidonic 
acid metabolites do not involve phosphorylation or 
dephosphorylation reactions as was described by Buttner 
et al (1989). They were able to show that 12-HPETE 
could increase the probability of "S" channel 
opening in cell free membrane patches in the absence of 
ATP and GTP: b) When cyclic AMP levels were elevated
' » *  • '  '' -• : ■ •>      . ; ■■
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FMRFamide was able to antagonize the actions of cyclic 
AMP by reopening ”S” channels. It is thought that 
this effect of FMRFamide was also mediated by a 
lipoxygenase arachidonic acid metabolism pathway. This 
eventually leads to the dephosphorylation of the "S" K+ 
channel (Sweatt et al. 1989). Given these actions of 
FMRFamide on the sensory neurones and their mediation 
of them by arachidonic acid and its metabolites, it was 
important to test if arachidonic acid was involved in 
the FMRFamide induced K"^  response of the Cl neurone.
When arachidonic acid was applied to the Cl 
neurone there was no mimic of the FMRFamide response or 
any effect on the response. Therefore, unlike the "S" 
channels of sensory neurones of Aplysia. FMRFamide 
does not appear to act through arachidonic acid or its 
metabolites on the Cl neurone.
4.2.8 PROTEIN PHOSPHORYLATION
To determine whether protein phosphorylation or 
dephosphorylation reactions are involved in the 
generation of the FMRFamide response, okadaic acid was 
used. This substance inhibits the protein 
dephosphorylating actions of protein phosphatases 1 and 
2A. If these protein phosphatases were operable in the 
Cl neurone, their inhibition should produce an increase 
in the level of protein phosphorylation.
When okadaic acid was applied to the Cl neurones, 
the amplitude of the FMRFamide response was greatly 
reduced. Therefore protein phosphatases 1 and /or 2A do
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appear to operate in the Cl neurone. The results 
suggest that higher protein phosphorylation levels lead 
to a smaller FMRFamide response. This result 
corresponds with those obtained with increased cyclic 
AMP levels and protein kinase C activation. Both 
treatments should have resulted in increased protein 
phosphorylation levels and, as was demonstrated, the 
amplitude of the FMRFamide response was reduced.
This result with okadaic acid is consistent with 
results reported by Sweatt et al (1989) in which 
Aplysia sensory neurones are demonstrated to respond to 
FMRFamide with increased open probability of ”S” K+ 
channels. The resting levels of protein phosphorylation 
were reduced in the presence of FMRFamide without 
acting on the level of cyclic AMP. It is also in 
agreement with work done by Ichinose and Byrne (1991), 
where intracellular application of okadaic acid reduced 
the amplitude of the FMRFamide induced outward K"^  
current in Aolysia sensory neurones. They suggested 
that FMRFamide may exert its effect through the 
activation of protein phosphatases. Slow diffusion of 
the catalytic subunits of protein phosphatases 1 and 2A 
produced a gradual outward shift in baseline current 
and this was associated with an increase in membrane 
input conductance. Thus these protein phosphatases 
mimicked the FMRFamide response.
Biochemical evidence for activation of protein 
phosphatases by transmitters was reported in striatal 
neurones where stimulation of NMDA receptors activates
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protein phosphatase 2B, leading to the 
dephosphorylation of DARPP-32 (Halpain et al, 1990).
FMRFamide may therefore activate protein 
phosphatases in the Cl neurone and hence reduce the 
levels of protein phosphorylation and opening of K+ 
channels.
4.2.9 SINGLE CHANNEL RECORDINGS
Single channel recordings were obtained from Cl 
neurones by employing the technique of cell attached 
patches. With this system an externally applied agonist 
has no direct means of access to the patch of membrane 
which is under investigation. Any contact must be made 
through the production of an intracellular second 
messenger.
Unitary Currents obtained from cell attached 
patches on the Cl neurone became more obvious at patch 
potentials more depolarized than -45mV. When the 
concentration of K'*' in the recording pipette was 
reduced from 5mM to ImM, the unitary currents were 
larger and easier to see at each potential. The channel
permeabilities were similar with 5mM or ImM K'*' in the
recording pipette. The permeability values obtained 
were 1.68 x IQ-^^cm^s""^ with 5mM K"^  and
1.62 X  lO^l^cm^s"! with ImM K"*".
No unitary currents were observed from patches 
when FMRFamide was applied to the outside of the cell 
body membrane. One reason for this may be that 
FMRFamide does not open the channels via the production
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of an intracellular second messenger. Another 
explanation could be that the FMRFamide receptors 
and/or ion channels opened up by FMRFamide are located 
in an inaccessible area for patch clamp recording. Such 
an area might be the axon hillock region of the 
neurone. One way to approach this problem would be to 
culture the neurones in spherical form (without axonal 
processes) and hope to see a redistribution of 
receptors or ion channels over the cell body which were 
originally located at the axon hillock.
4.3 CONCLUSION OF EXPERIMENTS ON THE Cl NEURONE
It has been shown that a pertussis toxin sensitive 
or Gq protein mediates the FMRFamide response. Of 
the second messenger systems examined, namely cyclic 
AMP, cyclic GMP, arachidonic acid, IP3 , Ca^^ and 
protein kinase C activation, none appeared to be 
directly involved in underlying the FMRFamide response.
The exclusion of these second messenger systems were 
supported by the negative results obtained from the 
cell attached patch experiments.
However, some substances did modulate the 
FMRFamide response. The neurotransmitter 5-HT and 
cyclic AMP both reduce the response amplitude. It 
seemed that 5-HT may have had this effect through the 
production of cyclic AMP. Protein kinase C activation A
also reduced the FMRFamide response as did higher 
levels of protein phosphorylation.
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Given the positive G protein results and negative 
direct effect of second messengers, the idea that the 
FMRFamide receptor may be coupled to the ion channel 
directly through the activation of a G protein is 
proposed. The first described and most thoroughly 
examined example of such a mechanism is the ACh 
activated inwardly rectifying K"^  channels in atrial 
cardiac myocytes (Soejima and Noma, 1984; Pfaffinger et 
al, 1985; Kurachi et al.1986a and b; Yatani et al,
1987a and b). The next question is how does protein à
phosphorylation and the suppression effects of 5-HT, |
cyclic AMP and protein kinase C activation fit into i
this scheme? It is possible that 5-HT acting through |
raised cyclic AMP levels and protein kinase C |
activation by diacylglycerol (DAG) could cause the JIphosphorylation of the FMRFamide receptor, G protein or |
ion channel and somehow reduce the activity of this 
complex. If protein phosphatases which dephosphorylate 
these proteins were inhibited, then this increase in 
protein phosphorylation may also reduce the FMRFamide 
response.
To test the validity of this model, many more 
patch clamping experiments would be required. Taking a 
similar approach as those who worked on the K*^  channel 
opened by ACh would be useful with perhaps the first 
step to get cell attached patches and to determine if 
FMRFamide in the recording pipette would have any 
effect (Soejima and Noma, 1984). If the results proved 
positive, the next stage would be to obtain inside out 
patches and see if channel activity remained. If
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channel activity was lost then addition of GTP to the 
inside face of the inside out patch might be expected 
to restore channel activity if a G protein was involved 
(Kurachi et al, 1986a), It would also be useful to 
check if this activity was abolished by pertussis toxin 
pretreatment of the neurones (Kurachi et al, 1986b). 
Finally, it could also be possible to apply a purified 
and activated G protein to the inside surface of the 
inside out patch and again determine whether channel 
activity reappeared (Yatani et al, 1987b). For a model 
of this system see Figure 4.1.
Another explanation of the results could be that 
FMRFamide activates protein phosphatase(s ) to reduce 
protein phosphorylation levels and open channels as was 
suggested by Ichinose and Byrne (1991) on Aplysia 
sensory neurones. Protein phosphorylation levels could 
be enhanced by 5-HT acting through cyclic AMP and DAG 
activation of protein kinase C, which would lead to a 
reduction in amplitude of FMRFamide responses. A model 
of this system is shown in Figure 4.2.
4.4 THE FAST DEPOLARIZING FMRFamide RESPONSE OF THE C2
NEURONE
FMRFamide induces a fast depolarizing response in 
the C2, F2 and E13 neurones of Helix apersa. In a study 
performed by Cottrell et al (1990), experiments were 
made on excised outside out patches from 0 2  neurones.
In some instances when FMRFamide was applied to these 
patches, unitary currents appeared. Since these patches
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Figure 4.1
A schematic representation of a possible mechanism 
which underlies the slow K'*' hyperpolarizing response of 
FMRFamide in the Cl neurone. In this model, the activated 
FMRFamide receptor housed in the lipid bilayer of the 
membrane is linked to the channel through the 
activation of a pertussis toxin sensitive Gj^  or Go 
protein. Protein phosphorylation on any of the proteins 
making up the receptor /G protein /ion channel complex 
may down regulate its activity.
5-HT acting on its membrane receptor probably 
activates adenylate cyclase through a Gg protein which 
leads to the elevation of cyclic AMP levels. Cyclic AMP 
activates cyclic AMP dependent protein kinase A which 
would increase protein phosphorylation levels. The 
activation of protein kinase C also results in increased 
protein phosphorylation and reduce the activity of the 
FMRFamide receptor /G protein /ion channel complex. 
Protein phosphatases 1 and /or 2A are able to 
dephosphorylate the proteins of the complex. Inhibition 
of these protein phosphatases by okadaic acid again leads 
to increased protein phosphorylation levels of the 
complex and a smaller FMRFamide response.
The abbreviations used in this model are:- R= 
receptor, Fa= FMRFamide, 5-HT= 5-hydroxtryptamine, Gg= G 
protein which stimulates adenylate cyclase,0^= G protein 
which inhibits adenylate cyclase, Gq = G protein with some 
other function, += an activation of, or increased levels 
of, as appropriate, -= reduced levels of. The bilayer of 
the cell membrane is represented by the shaded circles 
and the area between them.
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Figure 4.2
À schematic representation of another possible 
mechanism which underlies the slow hyperpolarizing K+ 
response of FMRFamide in the Cl neurone. In this model, 
FMRFamide acting on its receptor activates a or Gq 
protein which is linked by some intracellular mechanism 
to the activation of protein phosphatase 1 and /or 2A. 
Protein phosphorylation of the ion channel by these 
protein phosphatases leads to K'*' channel opening.
5-HT acting on its receptor to stimulate Gg and 
hence adenylate cyclase raises cyclic AMP levels. Cyclic 
AMP activates cyclic AMP dependent protein kinase A which 
can phosphorylate the FMRFamide receptor, G^ /Gq protein 
or the channel itself which causes the closure of the 
channel. The stimulation of protein kinase C may also 
lead to the phosphorylation of these proteins leading to 
the closure of the channel.
The abbreviations used in this model are:- R= 
receptor, Fa= FMRFamide, 5-HT= 5-hydroxytryptamine, Gg= G 
protein which inhibits adenylate cyclase, Gq = G protein 
with some other function, P= protein phosphorylation, += 
an activation or increased levels of, as appropriate, -= 
inactivation of or reduced levels of, as appropriate. The 
lipid bilayer of the cell membrane is represented by the 
shaded circles and the area between them.
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were maintained in isolation from the C2 neurone for up 
to 2 0  minutes it was unlikely that a second messenger 
was directly underlying this response. Therefore, the 
only remaining explanation was that these were ligand 
gated channels opened by FMRFamide. This is most 
unusual since the effects of neuropeptides on neurones 
described to date have exclusively found that they 
operate through the generation of second messengers. 
Brezina et al (1988) have also reported that the fast 
FMRFamide induced Na"^  current is not mediated by the 
activation of a G protein.
Comparisons have been made between the partially 
characterized responses in the El3 and F2 neurones to 
FMRFamide (Cottrell et al. 1984? Cottrell et a l . 1987? 
Cottrell et al, 1990) and the response in the C2 
neurone. However, the response in the C2 neurone 
remained to be characterized.
4,4.1 DEPENDENCY OF THE RESPONSE ON Na+ AND Ca%+
To confirm that Na*^  was the charge carrier in the 
fast response, a modified saline containing ONa+ was 
applied to the neurone. The ONa+ saline diminished but 
did not completely abolish the response. The 
diminishing effect of ONa+ saline was reversed when 
normal saline was washed over the neurones. These 
experiments showed that the FMRFamide response was 
dependent on Na*^  and suggest that Na"*" carries most of 
the FMRFamide induced current in the C2 neurone.
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An effective and simple way to test whether Ca^^ 
ions are involved in the response is to apply C0 CI2 .
C0 CI2 has been previously shown to block the Ca^^ 
current of molluscan neurones (Akaike et a l . 1981).
This approach did not directly deprive the neurones of 
Ca2 + in the intracellular or extracellular environment 
as does happen when either EGTA is injected into the 
neurones or applying OCa^ "*" saline. Therefore any other 
Ca2 + dependent processes not directly affected by Ca^^ 
entry through these channels would still be expected to 
function.
When C2 neurones were bathed in a normal saline, 
which contained ImM C0 CI2 , there was no change in the 
amplitude of the FMRFamide response. These results
indicate that the fast FMRFamide current is not carried î|Iby Ca2 + and that Ca^^ are not required in another way j
for the generation of the response. |j
4.5 SEARCH FOR A BLOCKER OF THE FAST FMRFamide J
RESPONSE
A number of substances known to block Na"^  channels 
and to antagonize receptors which lead to the opening 
of Na*^  channels were used.
4.5.1 TETRODOTOXIN fTTX^
TTX was the first substance tested on the C2 
neurone. A long term exposure of the neurones to 50/iM 
TTX (20 minutes) had no effect on the amplitude of the
1 1 9
FMRFamide responses. TTX is a substance which is known 
to selectively block voltage sensitive Na"^  currents Î
(Moore et a l . 1967). The FMRFamide response of the C2 
neurone is voltage independent. Therefore, it was 
expected that TTX would have no effect. TTX has also 
been shown to be unsuccessful in blocking the 
depolarizing responses of FMRFamide in other Helix 
neurones such as Dl, D2, D4, E14, E15 and F77 (Boyd and 
Walker, 1985).
4.5.2 LIGNOCAINE
The local anaesthetic lignocaine was applied to 
the C2 neurone. Such drugs block the transient increase 
in Na"*" permeability that generates the rising phase of 
the spike potential in response to depolarizing 
currents (Covine, 1971? Lechat, 1971). This Na"*" channel 
blocker had no effect on the amplitude of the FMRFamide 
response.
4.5.3 AMILORIDE
Some Na"^  channels of the apical membranes of tight 
epithelia are blocked by low contrations of amiloride.
Hamilton and Eaton (1985) found that amiloride blocks 
the channel from the outside and that this reduces the 
mean open time in a voltage-dependent manner without 
altering the single channel conductance. Amiloride has 
also been shown to block mechano-electrical 
transduction (MET) currents in dissociated hair cells
I
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of the chick (Jorgensen and Ohmori, 1988). The 
transduction channels are non selective to monovalent 
cations, although it is thought that K"^  is the ion 
which carries the major fraction of the receptor 
current. The blocking by amiloride of this current was 
reversible and both dose and voltage dependent on the 
MET channel.
When lOOjuM amiloride was applied to the C2 
neurone, the amplitude of the FMRFamide responses was 
almost completely blocked. This action of amiloride was 
fully reversible. Therefore, the most complete block in 
all of these experiments in terms of reducing the 
FMRFamide response amplitude and reversibility was 
achieved with amiloride.
4.6 EFFECT OF CYCLIC AMP ON THE FMRFamide RESPONSE OF
THE C2 NEURONE
Song and Huang (1990) made an interesting 
discovery when examining glycine receptor channels in 
neurones isolated from the spinal trigeminal nucleus of 
the rat. These channels are thought to belong to a 
superfamily of ligand gated channels of which nicotinic 
ACh receptors and GABA^ receptors belong. The Cl~ 
currents induced by glycine in these neurones were 
potentiated in the presence of elevated cyclic AMP 
levels and also by the activation of cyclic AMP 
dependent protein kinase A. The activation of a Gg 
protein was also involved in this potentiation. Since 
it is now known that the Na"^  channels opened by
i
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FMRFamide in the C2 neurone are ligand gated (Cottrell 
et al. 1990), the question was, do elevated levels of 
cyclic AMP potentiate the FMRFamide response in the C2 
neurone?
When ImM dibutyryl cyclic AMP was applied to C2 
neurones, FMRFamide responses were potentiated. The 
potentiation was reversed when the soluble analogue was 
washed away. A small inward current was induced by 
dibutyryl cyclic AMP. This was not surprising as 
discussed in relation to the Cl neurone when membrane 
soluble analogues of cyclic AMP induced an inward 
current. This is quite a common action of raised cyclic 
AMP levels in molluscan neurones. Overall these results 
suggest that the FMRFamide response is influenced in a 
positive manner by raised cyclic AMP levels.
Another membrane soluble analogue of cyclic AMP, 
8-(-4) CPT cyclic AMP produced a larger potentiation of 
the FMRFamide response compared to dibutyryl cyclic AMP 
and a larger inward current. These large effects of 8 - 
(-4) CPT cyclic AMP can be explained by the fact that 
this compound is more resistant to phosphodiesterase 
breakdown. Application of the phosphodiesterase 
inhibitor IBMX had similar effects to those of the 
membrane soluble analogues of cyclic AMP. Cyclic AMP 
itself, which is not membrane soluble, did not effect 
the FMRFamide response as was expected. These results 
suggest that raised cyclic AMP levels potentiate the 
FMRFamide response.
The question which remained after these 
experiments was, how does cyclic AMP potentiate the
.1-.
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response? Do raised cyclic AMP levels activate cyclic 
AMP dependent protein kinase A to increase protein 
phosphorylation, or does cyclic AMP have some other 
effect on the receptor channel complex to potentiate 
the response? To investigate this, 8 -(-4) CPT cyclic 
AMP was applied to C2 neurones simultaneously with 
okadaic acid and then the preparation was washed with 
okadaic acid alone, Okadaic acid inhibits protein 
phosphatases 1 and 2A (see above). The idea was that if 
raised cyclic AMP levels induced protein 
phosphorylation and potentiation of the FMRFamide 
response, okadaic acid would inhibit dephosphorylation 
and the potentiation of the FMRFamide response would be 
maintained.
When the combination of 8 -(-4) CPT cyclic AMP and 
okadaic acid was applied to the neurones, the response 
was potentiated as usual. Washing the preparation with 
okadaic acid caused the response amplitudes to return 
to control levels. This result appeared to rule out 
protein phosphorylation as a mechanism to potentiate 
the FMRFamide response. A direct potentiation of the 
response seems more likely. A possible model of this is 
shown in Figure 4.3. However, it should be noted that a 
protein phosphatase other than the 1 or 2 A type may be 
important and rapidly dephosphorylates the channels or 
their associated proteins. One way to overcome this 
problem would be to inject activated cyclic AMP 
dependent protein kinase A and see if the FMRFamide 
response was potentiated.
Figure 4.3
A schematic diagram of a possible mechanism 
underlying the potentiating effect of cyclic AMP on the 
FMRFamide induced fast depolarizing response of the C2 
neurone. The evidence indicates that cyclic AMP has a 
direct effect on the protein(s) which make up the ligand 
gated channel. However, it is still possible that raised 
cyclic AMP levels may activate cyclic AMP dependent 
protein kinase A which could phosphorylate the channel 
proteins and cause the potentiation of the FMRFamide 
response.
The abbreviations used in this diagram are:- 
R-receptor, Fa= FMRFamide, P= protein phosphorylation, += 
potentiation, activation of and increased levels of, as 
appropriate. The lipid bilayer of the cell membrane is 
represented by the shaded circles and the area between 
them.
Na
Fa
[+P]
cyclic AMP 
dependent 
protein  
kinase A
cyclic
AMP
■- ' ôi ■
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The idea that cyclic AMP may directly potentiate 
the FMRFamide response is not unique. Recently Di 
Francesco and Tortora (1991) examined the activation of 
cardiac pacemaker channels by raised cyclic AMP levels. 
They found using excised patch experiments that cyclic 
AMP activated the hyperpolarization-activated current 
by a mechanism which did not involve protein 
phosphorylation. The effect of cyclic AMP involved a 
direct interaction with the channels on the cytoplasmic 
side. This action of cyclic AMP was found not to be 
mediated by a G protein.
4.7 OVERVIEW
Peptides are an important group of extracellular 
messengers. They occured early in evolution and 
probably pre-dated some of the other classes of 
chemical messengers. Because of their structural 
diversity, peptide molecules offer an extensive 
vocabulary of signals. Up to 10-15 years ago it was 
thought that peptides were only used in different 
animal groups for long distance "chemically addressed" 
hormonal signalling. However, since then there has been 
an explosion of information showing that neuropeptides 
are present in the nervous system. Evidence from 
studies on both vertebrate and invertebrate animals 
indicates that many neuropeptides also have 
"transmitter-like" actions in that they can be 
"spatially addressed" close to their site of action. 
Therefore neurotransmission does not appear to be only
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mediated by low molecular weight substances as was 
thought previously.
There are some problems in studying peptide 
functions especially within the CNS. The peptides 
generally occur in very low concentrations; 
immunocytochemical procedures which can be used to 
detect them are often insufficiently selective to 
identify a particular member of a peptide family and 
individual members of a peptide family often have 
markedly different effects to one another, sometimes 
even opposing actions. With vertebrate preparations it 
can be extremely difficult to examine the action of 
neuropeptides because the cells are small and 
heterogeneous. Therefore, experiments are best done on 
systems which are likely to yield unambiguous data such 
as simple preparations ideally comprising only a few 
identified cells with known properties that can be 
studied by a wide range of techniques.
The experiments detailed in this thesis have 
examined two different ionic currents induced by the i
neuropeptide FMRFamide in the mollusc Helix aspersa.
The advantages of using this preparation are that this 
neuropeptide and others related to it are endogenous to 
the animal and that the neurones on which to study the 
actions of FMRFamide are large and readily 
identifiable.
The profile of the FMRFamide induced current in 
the Cl neurone is slow which suggests that the receptor 
is not directly linked to the ion channel. The evidence 
presented shows that a or Gq protein is involved but
■;
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the response is not directly mediated through the 
action of a second messenger substance. It seems likely 
that the ion channel is linked to the receptor through 
the G protein. This effect of a neuropeptide on nervous 
system is similar to that described by the activation 
of ACh muscarinic receptors in atrial cardiac myocytes.
The FMRFamide response examined in the C2 neurone 
was unusual for a neuropeptide. Previous studies have 
shown that this fast Na"*" response is ligand-gated which 
is absolutely unique in the world of neuropeptides 
described to date. The receptor-channel complex may 
well be related to the superfamily of ligand gated 
channels, examples of which are the ACh nicotinic 
receptor and the GABA^ receptor. This relationship may 
be confirmed by molecular biological techniques and so 
prove to be an example of convergent evolution. 
Characterization of the response in the C2 neurone 
showed that it was Ca^'^-independent and was blocked by 
amiloride. The response was shown to be potentiated by 
the second messenger cyclic AMP. This evidence 
indicates that ligand-gated channels may be modulated 
by intracellular second messenger levels, either by 
direct actions or possibly through protein 
phosphorylation. Overall the results detailed in this 
thesis illustrate how electrophysiological techniques 
may be used to examine the roles, mechanisms of action 
and receptors of neuropeptides in the nervous system.
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Summary
1 2 4
1. FMRFamide induces a slow hyperpo lari zing K"^  current 
in the Cl neurone and a fast depolarizing Na"*" current 
in the C2 neurone of Helix aspersa. Both effects were 
examined in this study.
2. The slow current of the Cl neurone was mimicked 
by the intracellular injection of the non-hydrolysable 
GTP analogue, GTPuS* This substance also occluded the 
FMRFamide response. A G protein therefore appears to be 
involved in the response.
3. Pre-activated pertussis toxin injected into the 
cell body of the Cl neurone reduced the amplitude of 
the FMRFamide response which indicated that the G 
protein involved was of the G^ or Gq type.
4. Raised cyclic AMP levels produced by application of 
the membrane soluble analogue ImM 8 -(-4) CPT cyclic AMP 
caused a reduction in the amplitude of the FMRFamide 
response of the Cl neurone and the development of an 
inward current.
5. 100/iM 5-HT also produced a reduction in FMRFamide 
response amplitude of the Cl neurone and an inward 
current. Both of these effects were potentiated and 
prolonged by the simultaneous application of the 
phosphodiesterase inhibitor ImM IBMX, which indicated 
that 5-HT acted through cyclic AMP production. The 
channels opened by FMRFamide and closed by 5-HT may be 
an "S" K"^  type channel.
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6 . A membrane soluble analogue of cyclic GMP, ImM 8 - 
bromo cyclic GMP had no effect on the amplitude of the 
FMRFamide response of the Cl neurone, but did produce 
an inward current.
7. Injection of IP3 into the neuronal cell body had no 
effect on the baseline current level of the Cl neurone.
8 . Activation of protein kinase C by 50/iM phorbol 
12,13-dibutyrate irreversibly reduced the amplitude of 
the FMRFamide response of the Cl neurone and produced a 
reversible inward current.
9. Application of 50/iM arachidonic acid to the Cl 
neurone had no effect on the amplitude of the FMRFamide 
response and did not mimic the response.
10. Experiments designed to reduce intracellular Ca^^ 
concentration either by injecting the Ca^^ chelator 
EGTA, or removing Ca^^ from the extracellular 
environment, had no effect on the amplitude of the 
FMRFamide response of the Cl neurone. These treatments 
did induce an inward current, which may have been due 
to the closure of Ca^^ dependent K"^  channels.
11. Application of 1/iM okadaic acid, the protein 
phosphatase 1 and 2A inhibitor, reduced the amplitude 
of the FMRFamide response of the Cl neurone indicating 
that increased protein phosphorylation levels make it 
more difficult for FMRFamide to open the channels.
12. Patch clamp experiments with cell attached patches 
on the Cl neurone indicated that at patch potentials
response was reversibly potentiated. The increased
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near resting membrane potential (-45mV), unitary 
currents were not observed. Unitary currents did become 
obvious at more depolarized patch potentials. They were 
thought to be voltage dependent K*^  channels. FMRFamide 
application at patch potentials near resting membrane 
potential did not result in the occurence of outward 
unitary currents.
13. The fast depolarizing response of FMRFamide in the 
C2 neurone was characterized. The current was shown to 
be mainly carried by Na"*" since the response was almost 
abolished with ONa+ saline. Blockage of the Ca^^ 
channels by ImM CoClg did not affect the response.
14. 100/iM amiloride reversibly blocked the FMRFamide 
response of the C2 neurone.
15. Application of the Na"^  channel blocker tetrodotoxin 
(50/iM) and the local anaesthetic lignocaine (ImM) had 
no effect on the FMRFamide response of the C2 neurone.
16. The membrane soluble analogues of cyclic AMP, ImM 
dibutyryl cyclic AMP and ImM 8-(-4) CPT cyclic AMP 
reversibly potentiated the FMRFamide response of the 02 
neurone. ImM IBMX had the same action on the response.
All of these treatments also induced inward currents 
which were not examined in detail.
17. When the 02 neurone was bathed in ImM 8 -(-4) OPT 
cyclic AMP simultaneously with IjuM okadaic acid and I 
then washed with 1/xM okadaic acid alone, the FMRFamide
1 2 7
protein phosphorylation levels induced by okadaic acid 
had no effect. Thus the effect of raised cyclic AMP 
levels may be direct and not involve protein 
phosphorylation.
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